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Abstract 
 
National guidelines for stroke recommend that all patients entering 
rehabilitation are screened for mood disturbance using a validated measure. The first 
half of this thesis presents a literature review of 25 self-report screening measures for 
the detection of post-stroke distress.  A total of 26 studies were identified as meeting 
the search criteria. Fifteen self-report measures met recommended levels of 
sensitivity (≥0.80) and specificity (≥0.60) when screening for post-stroke depression. 
The Hospital Anxiety and Depression Scale (HADS) was the only measure to meet 
recommended levels of accuracy for post-stroke anxiety. At the commencement of 
this thesis, the Distress Thermometer (DT) had not been validated among stroke 
survivors despite being recommended by NICE (2009).  
 
The study presented in the second half of this thesis investigates the 
diagnostic accuracy and clinical utility of the DT and associated Problem List (PL), 
the Brief Assessment Schedule Cards (BASDEC), and the Yale. Relative to the 
HADS, the area under the curve (AUC) for the DT was significantly greater than an 
AUC of 0.50. Cut-off scores of at least 4 and 5 on the DT met recommended levels 
of sensitivity and specificity when screening for post-stroke depression and anxiety. 
The accuracy of the BASDEC and Yale was non-significant. Due to a small sample 
size, these results should be taken with caution. However, this study provides 
preliminary evidence to support the use of the DT and PL as a holistic and person-
centred screening tool for the prevention and recognition of post-stroke distress.     
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Abstract 
 
The following review examines the diagnostic accuracy and clinical utility of 
25 self-report screening measures for the detection of post-stroke distress.  Empirical 
studies in AMED, CINAHL, EMBASE, MEDLINE and PsycINFO published up 
until 15
th April 2012 were considered. The following search terms were applied: 
stroke OR cerebrovascular accident AND distress OR mood OR depression OR 
anxiety AND screen OR assessment OR measure OR scale OR tool AND sensitivity 
OR specificity. A total of 26 studies were identified as meeting the search criteria.  
 
Three ultrashort measures (1-4 items), five short measures (5-20 items), and 
seven long measures (≥ 21 items) met recommended levels of sensitivity (≥0.80) and 
specificity (≥0.60) when screening for depression. The Hospital Anxiety and 
Depression Scale (HADS) was the most frequently validated measure within this 
review. However, it was the only measure to meet adequate levels of accuracy when 
screening for post-stroke anxiety. Due to methodological variation, recommended 
cut-off scores for each measure varied between studies. This is likely to reflect the 
heterogeneous nature of stroke and highlights a need to validate measures throughout 
the stroke care pathway. At the commencement of this study, the Distress 
Thermometer (DT) had not been validated among stroke survivors, despite being 
recommended by NICE (2009) when screening for depression among people with 
chronic physical health needs. In conclusion, future studies are needed to establish 
appropriate cut-off scores when using screening measure within stroke services, 
particularly for the detection of post-stroke anxiety.  
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Introduction 
 
Post-Stroke Distress 
 
It is estimated that 110,000 people experience a stroke in England every year 
(National Audit Office, 2005). While survival rates have improved (de Freitas, 
Bezerra, Maulaz, & Bogousslavsky, 2005) stroke is the most common cause of 
“complex disability” compared to any other chronic condition (Adamson, Beswick, 
& Ebrahim, 2004, p. 174).  
 
Gainotti (1993) considers emotional disorders to be one of the most 
important factors in determining the outcome and success of rehabilitation following 
brain injury.  Post-stroke emotional distress is common and can be defined as a 
negative mood state ranging from clinically significant mood disorders to less 
intense and persistent states of emotional adjustment (Carney & Freedland, 2002; De 
Wit et al., 2008).  
 
Depression is one of the most frequently researched areas of post-stroke 
distress (Carney & Freedland, 2002). Although prevalence rates differ across studies 
due to methodological variation, pooled results suggest that 33% of people will 
experience depression within five years of having a stroke (Hackett, Yapa, Parag, & 
Anderson, 2005). Furthermore, patients identified as being depressed within the 
acute phase of recovery are at a heightened risk of remaining depressed in the long-
term (Ayerbe, Ayis, Rudd, Heuschmann, & Wolfe, 2011).   
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Less attention has been paid to post-stroke anxiety (Campbell Burton et al., 
2011), yet prevalence rates are thought to be similar to depression (De Wit, et al., 
2008). Moreover, comorbid anxiety and depression has been found to occur in 46% 
of stroke inpatients (Castillo, Starkstein, Fedoroff, & Price, 1993) and is thought to 
increase the severity and duration of depressive symptoms (Shimoda & Robinson, 
1998). Until recently, the majority of studies within the stroke literature have 
investigated the prevalence of generalised anxiety disorder. However, the 
acknowledgement of other anxiety disorders such as posttraumatic stress disorder 
(PTSD) is growing (Merriman, Norman, & Barton, 2007).  
 
Non-clinical levels of distress may also increase the risk of developing mood 
disorders and therefore warrant early intervention as a preventative measure (Taylor, 
Todman, & Broomfield, 2011). Some people may experience less intense and 
persistent states of emotional distress (Barton, 2007). Other mood related difficulties, 
such as anger, denial, frustration and loss of confidence are also known to occur as 
part of the adjustment process (Ch'Ng, French, & Mclean, 2008).  
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Biopsychosocial Model  
 
The development and maintenance of post-stroke distress is complex 
(Gainotti, 1993). The International Classification of Functioning, Disability and 
Health’s (ICF) biopsychosocial model highlights a “dynamic interaction” between a 
health condition, functioning, and contextual factors (Figure 1). Change in one area 
of this model is thought to have the potential to modify other areas of functioning. 
Furthermore, a bidirectional relationship may exist where the health condition or 
associated disability may contribute to the development of emotional distress and 
vice versa (World Health Organization [WHO], 2001, p. 26).  
 
In line with the ICF model, post-stroke distress has been associated with 
reduced functional outcome
 and quality of life (Pohjasvaara, Vataja, Leppävuori, 
Kaste, & Erkinjuntti, 2001), reduced cognition (Shimoda & Robinson, 1998), 
increased mortality (House, Knapp, Bamford, & Vail, 2001; Teasdale & Engberg, 
2001), and increased stress on carers (Anderson, Linto, & Stewart-Wynne, 1995). In 
turn, post-stroke depression is thought to place additional demands upon health care 
resources through lengthened hospital stays, increased outpatient visits, and 
increased risk of readmission and institutionalisation (Ghose, Williams, & Swindle, 
2005; Kotila, Numminen, Waltimo, & Kaste, 1999). Furthermore, the additive effect 
of comorbid anxiety and depression has been associated with higher impairments of 
activities of daily living, cognition, and social support compared to either condition 
alone (Shimoda & Robinson, 1998). Consequently, the early detection of post-stroke 
distress seems important to prevent increasing distress and to improve quality of life 
and functional outcome.  
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Figure 1. The ICF integrative biopsychosocial model of functioning and disability 
(WHO, 2001). 
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Mood Screening  
 
The National Clinical Guideline for Stroke (Intercollegiate Stroke Working 
Party, 2008) recommends that all patients entering rehabilitation and thereafter 
should be screened for depression and anxiety using a validated measure. Over the 
years, compliance with these guidelines has been low. While this is improving 
(Royal College of Physicians, 2011), factors such as reluctance to ask sensitive 
questions, time pressure, lack of knowledge, and poor awareness of guidelines 
continue to prevent screening (Hammond, O'Keeffe, & Barer, 2000; Hart & Morris, 
2008).  
 
An array of measures exist which can be used to screen for mood related 
problems. However, the majority have been developed for psychiatric populations 
and contain somatic symptoms, such as loss of appetite and poor sleep, which may 
mimic physical, environmental, and cognitive problems following stroke (Roger & 
Johnson-Greene, 2009). The gold standard method for assessing mood is the 
structured clinical interview. However, this is often time consuming and impractical 
on busy medical wards (Sagen et al., 2009). Consequently, self-report measures have 
been developed due to their brevity, yet completion is reliant upon the individual 
having good insight, memory and communication into their emotional status (Taylor, 
et al., 2011).  
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To overcome communication difficulties, self-report visual analogue scales 
tend to be used. This is despite research suggesting that stroke patients are unable to 
use them (Price, Curless, & Rodgers, 1999) as they offer the only means of self-
assessment (Benaim, Cailly, Perennou, & Pelissier, 2004). While observational 
measures and proxy reports are thought to be more practical (Lincoln, Kneebone, 
Macniven, & Morris, 2012), evidence has highlighted poor concordance rates 
between subjective reports of well-being and observer ratings (Berg, Lönnqvist, 
Palomäki, & Kaste, 2009; Edwards et al., 2006). Furthermore, observational 
measures rely upon external indicators of mood; whereas disorders of emotional 
expression, such as emotionality, apathy, and dysprosodia may mask or mimic 
internal states of distress and result in misclassification of emotional difficulties.  As 
a result, guidelines recommend visual analogue scales in addition to proxy ratings 
when screening someone with cognitive and communication difficulties (Gillham & 
Clark, 2011). 
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The Ideal Measure 
 
A stepped care approach to psychological care has been proposed which 
involves local service providers developing their own mood assessment pathway. 
The Stroke Improvement Programme (SIP) argues that at level one all patients 
should be screened for mood disorders using a simple and brief standardised measure 
(Gillham & Clark, 2011). Those identified as having a possible mood disorder are 
then offered further assessment and intervention. Lincoln et al. (2012) suggest that 
the ideal screening measure be easy to use, require minimal training and resources, 
and be accessible in a variety of settings, including bedside administration. To ensure 
generalisability, measures also need to be validated in subgroups of stroke survivors 
to establish reliable cut-off scores. As a result, it is up to local service providers to 
establish mood assessment pathways which meet the needs of the stroke population 
at hand.  
 
The sensitivity and specificity of a new measure (also known as the index 
test) relative to a gold standard or criterion standard, offer the best indicators of 
accuracy when choosing a validated measure (Glasziou & Irwig, 2001; Whiting et 
al., 2004). Sensitivity refers to the proportion of people with a clinically significant 
mood disorder (as measured by the criterion standard) who are correctly identified 
by the index test. In contrast, specificity refers to the proportion of people without a 
clinically significant mood disorder who are correctly identified as not having a 
mood disorder by the index test.  
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To ensure that the majority of people with a clinically significant mood 
disorder are detected, several authors recommend that the sensitivity of a screening 
measure be greater than its specificity (Berg, et al., 2009; House, Dennis, Hawton, & 
Warlow, 1989; Parikh, Eden, Price, & Robinson, 1988). However, Lincoln, Nicholl, 
Flannaghan, Leonard and van der Gucht (2003) point out that a measure with low 
specificity is no better than carrying out a full assessment with all patients. 
Consequently, a balance is required. Within stroke, Bennett and Lincoln (2006) 
recommend a sensitivity of at least 0.80 and a specificity of at least 0.60.  
 
Review Questions 
 
The aim of the review was to critically evaluate available self-report 
screening measures for post-stroke distress; to find out what current self-report 
measures are available, and to evaluate the diagnostic accuracy and clinical utility of 
each measure at discriminating between people with and without clinical levels of 
post-stroke distress. 
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Method 
 
Search Criteria 
 
Empirical studies in AMED, CINAHL, EMBASE, MEDLINE, and 
PsycINFO published up until 15
th April 2012 were considered. The following search 
terms were applied (see Appendix A for a detailed search strategy). 
 
1.  Stroke OR cerebrovascular accident AND  
2.  Distress OR mood OR depression OR anxiety AND  
3.  Screen OR assessment OR measure OR scale OR tool OR questionnaire 
OR instrument AND  
4.  Sensitivity OR specificity   
 
Duplicates were discarded and further studies were identified via cross-referencing. 
The following criteria were then applied. 
 
Inclusion criteria 
 
  The participants had a primary diagnosis of stroke  
  The participants were over the age of 18 years  
  The study was published in English 
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Exclusion criteria 
 
  The paper contained no primary data  
  The participants were carers of stroke survivors 
  The focus of the study investigated the prevalence, predictor or treatment of 
post-stroke distress, or the assessment of change over time 
  The measure was created to detect quality of life 
  The study did not investigate criterion-related validity or provide cut-off 
scores to detect clinically significant cases of post-stroke distress 
  The measures being validated were observer or clinician rated scales 
 
Evaluation Criteria 
 
Studies included in the review were evaluated in relation to the diagnostic 
accuracy and clinical utility of each measure. Diagnostic accuracy was evaluated in 
relation to guidelines proposed by Bennett and Lincoln (2006) which suggest that the 
sensitivity of a scale should be at least 0.80 and the specificity of a scale should be at 
least 0.60. To assess clinical utility, five factors were evaluated. These included the 
length of the measure, the type of training required to administer the measure, the 
response format of the measure, the generalisation of sample characteristics to 
clinical settings, and the cost of purchasing the measure. The length of each measure 
was categorised according to three arbitrary labels defined by a recent review within 
cancer where “ultrashort” measures consist of 1 to 4 items, “short” measures consist 
of 5 to 20 items, and “long” measures consist of 21 to 50 items (Vodermaier, Linden, 
& Siu, 2009).   
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Results 
 
Twenty six studies met the criteria for inclusion in the review. A total of 25 
self-report screening measures were described, as detailed below. A summary table 
containing each measure and associated study is presented in Appendix B.  
 
Beck Anxiety Inventory (BAI)  
 
The BAI (Beck & Steer, 1993) is a 21-item self report questionnaire designed 
to measure the severity of anxiety symptoms in a psychiatric population over the last 
week. Each item is rated on a 4-point multiple choice scale with a maximum score of 
63. A cut-off score of 0-7 is considered minimal, scores of 8-15 are mild, scores of 
16-25 are moderate, and scores between 26 -63 are severe.  
 
One study was identified in the review as validating the BAI among a sample 
of 44 community based stroke survivors (Schramke, Stowe, Ratcliff, Goldstein, & 
Condray, 1998). A cut-off score of at least 16 was found to have good sensitivity but 
poor specificity when detecting anxiety disorders relative to the DSM-III-R criteria. 
However, the authors did not provide any figures to support this finding. 
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Beck Depression Inventory (BDI and BDI-II) 
 
The BDI (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) and revised 
BDI-II (Beck, Steer, & Brown, 1996) comprise a  21-item self report questionnaire 
designed to measure symptoms of depression in a psychiatric population. Each item 
is rated on a 4-point multiple choice scale with a maximum score of 63. Items on the 
BDI are rated within the last week, whereas items of the BDI-II are rated within the 
past two weeks. Moreover, items involving change in body image, hypochondria, 
and difficulty working were replaced in the BDI-II and two items were revised to 
assess both increases and decreases in sleep and appetite. Cut-off scores for the BDI 
and BDI-II are presented in Table 1.  
 
Table 1 
Standard Cut-Off Scores for the BDI and BDI-II 
 
 
 
 
 
 
 
 
Three studies with a combined total of 424 participants were identified as 
validating the BDI among a sample of stroke survivors (Aben, Verhey, Lousberg, 
Lodder, & Honig, 2002; Berg, et al., 2009; House, et al.,1989).  
Interpretation  Cut-off 
  BDI  BDI-II 
      Minimal  0-9  0-13 
Mild  10-18  14-19 
Moderate  19-29  20-28 
Severe  30-63  29-63  
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House et al. (1989) questioned the accuracy of the BDI as a screening tool 
due to poor specificity relative to the DSM-III criteria for depression. While the 
sensitivity of the BDI met recommended levels of at least 0.80 at 1 month, 6 months 
and 12 months post-stroke, the specificity (≤ 0.59) of the BDI was poor at all three 
time points.  
 
In two more recent studies, the BDI was found to meet recommended levels 
of accuracy. Aben et al. (2002) evaluated the accuracy of the BDI relative to the 
DSM-IV diagnosis of depression at 1 month post-stroke (sensitivity: 0.80; 
specificity: 0.61), while Berg et al. (2009) found the BDI to be acceptable at 2 weeks 
and at 2, 6, 12 and 18 months post-stroke. An optimal cut-off score of at least 10 was 
recommended in both studies when screening for depression at 2 weeks, and at 1, 2, 
12 and 18 months. However, Berg, et al. (2009) suggested using a lower cut-off 
score of at least 7 at 6 months in order to maintain an adequate level of sensitivity 
and specificity (see Table 2 for a summary of cut-off scores). 
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Table 2 
Stroke Related Cut-Off Scores for the BDI  
Study  Time since stroke  Cut-off 
      House et al. (1989)  1 month  ≥5 
  6 months  ≥5 
  12 months  ≥5 
Aben et al. (2002)  1 month  ≥10‡ 
Berg et al. (2009)  2 weeks  ≥10‡ 
  2 months  ≥10‡ 
  6 months  ≥7‡ 
  12 months  ≥10‡ 
  18 months  ≥10‡ 
‡ Cut-off meeting recommended levels of sensitivity (≥0.80) and specificity (≥0.60) 
 
Three studies with a total of 329 participants validated the BDI-II within 
stroke (Lincoln, et al., 2003; Turner-Stokes, Kalmus, Hirani, & Clegg, 2005; Turner 
et al., 2012). The BDI-II was found to meet recommended levels of accuracy in one 
study, as outlined in Table 3 (Turner, et al., 2012).  
 
Lincoln et al. (2003) evaluated the accuracy of the BDI-II at detecting cases 
of major and minor depression relative to the Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN; WHO, 1992).  The BDI-II was found to have a good level 
of sensitivity (0.91, 0.83) but poor specificity (0.56, 0.44) when detecting DSM-III-R 
and ICD-10 cases of depression respectively. Furthermore, the optimal cut-off score 
varied according to the DSM-III-R (≥16) or ICD-10 (≥13) criteria.   
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Turner-Stokes et al. (2005) recommended using a higher cut-off score of at 
least 14 to detect DSM-IV cases of major and minor depression among a sample of 
younger inpatient stroke survivors (16-65 years). However, while specificity was 
good (0.80), the sensitivity of the BDI-II fell short of recommended levels (0.74).  
 
More recently, Turner et al. (2012) evaluated the performance of the BDI-II 
at detecting DSM-IV cases of major depression with a heterogeneous sample of 
stroke survivors between 3 weeks and 45 years post-stroke. A lower cut-off score of 
at least 11 was recommended in order to meet adequate levels of sensitivity (0.92) 
and specificity (0.71).  
 
Table 3 
Stroke Related Cut-Off Scores for the BDI-II  
Study  Criterion standard  Time since stroke  Cutoff 
        Lincoln et al. (2003)  DSM-III-R  Up to 6 months  ≥16 
  ICD-10  Up to 6 months  ≥13 
Turner-Stokes et al. (2005)  DSM-IV  12 weeks  ≥14 
Turner et al. (2012)  DSM-IV  3 week – 45 years  ≥11‡ 
‡ Cut-off meeting recommended levels of sensitivity (≥0.80) and specificity (≥0.60) 
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Beck Depression Inventory-Fast Screen (BDI-FS) 
 
The BDI-FS (Beck, Steer, & Brown, 2000) is a 7-item self-report measure 
taken from the BDI-II. Somatic items are excluded to increase specificity for medical 
patients. Cut-off scores of 3-5 are recommended. 
 
One study met the search criteria for validating the BDI-FS within stroke. 
Healey, Kneebone, Carroll and Anderson (2008) investigated the accuracy of the 
BDI-FS at detecting DSM-IV cases of depression in 49 inpatient stroke survivors. 
The BDI-FS demonstrated acceptable internal consistency (Cronbach’s   = 0.75) 
and test-retest reliability over a 7-10 day period (t (43) = 0.63, p<0.001). Using a cut-
off score of at least 4, the specificity of the BDI-FS met recommended levels of 
accuracy, however sensitivity fell below 0.80 (sensitivity: 0.71, specificity: 0.74). 
The accuracy of the BDI-FS reduced further when detecting major and minor 
depression (sensitivity: 0.62, specificity: 0.78).  
 
Brief Assessment Schedule Depression Cards (BASDEC) 
 
The BASDEC (Adshead, Cody, & Pitt, 1992) was developed to screen for 
depression in elderly medical inpatients.  It contains 19 cards with statements 
relating to symptoms of depression, which the individual places next to a true or 
false card. A maximum score of 21 can be obtained with a score of at least 7 
indicating depression which may warrant further intervention.  
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One study was identified as validating the BASDEC within stroke (Healey, et 
al., 2008). The BASDEC had acceptable reliability (Kuder-Richardson Formula 20 = 
0.77, test-retest reliability: τ (43) = 0.66, p 0.001) and excellent criterion validity 
(sensitivity: 1.0, specificity: 0.95) when identifying cases of major depression using 
the standard cut-off score of at least 7. While the sensitivity (0.69) of the BASDEC 
dropped when detecting minor and major depression, the BASDEC provided better 
diagnostic accuracy than the BDI-FS and the depression subscale of the Hospital 
Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983).  
 
Centre for Epidemiologic Studies Depression Scale (CES-D) 
 
The CES-D (Radloff, 1977) is a 20-item self-report scale designed to 
measure symptoms of depression in the general population.  Items are rated on a 4-
point scale. A maximum score of 60 is generated and a standard cut-off score of at 
least 16 is used to indicate depression.  
 
Six studies with a total of 307 participants met the inclusion criteria for 
validating the CES-D among a population of stroke survivors (Agrell & Dehlin, 
1989; Parikh, et al., 1988; Roger & Johnson-Greene, 2009; Rybarczyk, Winemiller, 
Lazarus, & Haut, 1996; Schramke, et al., 1998; Shinar et al., 1986). In two out of the 
six studies the CES-D was shown to meet recommended levels of accuracy for a 
screening tool in stroke, as outlined in Table 4 (Parikh, et al., 1988; Rybarczyk, et 
al., 1996). 
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Three studies were identified which recommended using the standard cut-off 
score of 16. Shinar et al. (1986) examined the accuracy of the CES-D at detecting 
DSM-III cases of depression. Twenty-seven stroke survivors were assessed at 7 to 10 
days, 3 months and 6 months post-stroke. While Shinar et al. (1986) concluded that 
the CES-D could be used as a reliable and valid screening tool for assessing post 
stroke depression, it is notable that the sensitivity (0.73) of the CES-D fell short of 
more recent recommendations (Bennett & Lincoln, 2006). In a replica study, Parikh 
et al. (1988) demonstrated an adequate balance of sensitivity (0.90) and specificity 
(0.86) when using a larger sample of 80 stroke survivors. In contrast, Schramke et al. 
(1998) argued that the CES-D lacked specificity; however the authors reported no 
precise figures to support this conclusion.  
 
A further two studies recommended using higher cut-off scores when using 
the CES-D. Agrell and Dehlin (1989) assessed the accuracy of the CES-D in a 
sample of 39 outpatient stroke survivors. Using a cut-off score of at least 20, the 
CES-D correctly identified the majority of people who did not have depression 
(specificity 0.91). However, a large proportion of people who did have depression 
were not detected (sensitivity 0.56). In contrast, Rybarczk et al. (1996) evaluated the 
accuracy of the CES-D in a sample of 50 inpatients. The CES-D met recommended 
levels sensitivity (0.82) and specificity (0.65) when using a higher cut-off score of at 
least 26. In a more recent study by Roger and Johnson-Greene (2009) the accuracy 
of the CES-D fell below recommendations despite using an optimal cut-off score of 
at least 15 (sensitivity: 0.66; specificity: 0.68).  
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Table 4 
Stroke Related Cut-Off Scores for the CES-D  
Study  Time since stroke  Cutoff 
      Shinar et al. (1986)  7 days-6 months  ≥16 
Parikh et al. (1988)  1week-2 years  ≥16‡ 
Agrell and Dehlin (1989)  4 ms -2.5 years  ≥20 
Rybarczyk et al. (1996)  3-43 days  ≥26‡ 
Schramke et al. (1998)  Mean 3.61   ≥16 
Roger and Johnson-Green (2009)  Mean 8 days  ≥15 
‡ Cut-off meeting recommended levels of sensitivity (≥0.80) and specificity (≥0.60) 
 
Depression Intensity Scale Circles (DISCs) 
 
The DISCs (Turner-Stokes, et al., 2005) is a six point visual analogue scale, 
scored from 0 (no depression ) to 5 (most severe depression). Each point on the scale 
is represented by a circle filled in with increasing shades of grey. The patient is 
asked to rate how sad or depressed they feel on that day by pointing to a circle.  
 
One study was identified as validating the DISCs with a sample of 114 
inpatients with acquired brain injury including stroke (Turner-Stokes, et al., 2005). 
Based upon a cut-off score of at least 2, the DISCS was found to have a sensitivity of 
0.60 and specificity of 0.87 when detecting DSM-IV cases of depression in a 
younger adult population (16-65 years). Turner-Stokes et al. (2005) concluded that 
the DISCs showed acceptable validity as a screening tool for depression.            
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While the BDI-II was found to be superior, the visual format of the DISCs was 
thought to be more accessible to those with severe communication difficulties.  
 
Distress Thermometer (DT) 
 
The DT (Roth et al., 1998) is a 1-item self-report screening tool developed to 
measure psychological distress among cancer patients. It consists of an 11-point 
visual analogue scale, measuring distress from 0 (no distress) to 10 (extreme 
distress).  A cut-off score of 4 is recommended within oncology to indicate those 
who may require further assessment (National Comprehensive Cancer Network 
[NCCN], 2010).  
 
One study with a sample of 72 participants was identified as validating the 
DT among a population of stroke survivors (Turner, et al., 2012). The accuracy of 
the DT was compared to DSM-IV criteria for major depression. The standard cut-off 
score of at least 4 did not meet recommended levels of sensitivity (0.69) and 
specificity (0.57).  When using a lower cut-off score of at least 2, those with major 
depression were correctly identified by the DT (sensitivity: 1.0); however, a number 
of people without clinical levels of depression were incorrectly classified as having 
depression (specificity: 0.33). The authors concluded that due to the DT measuring 
global distress in a single item, poor specificity may have related to the DT capturing 
a range of non-depressive states of post-stroke distress.  
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General Health Questionnaire (GHQ-30 and GHQ-28) 
 
The GHQ  (Goldberg & Williams, 1991) is a self-report measure designed to 
screen for psychiatric disorders within the last few weeks. Two versions of the GHQ 
have been validated in stroke. The GHQ-30 consists of 30 items and the GHQ-28 
contains 28 items, both of which are rated on a 4-point scale.  A cut-off score of at 
least 5 is recommended.  Unlike the GHQ-28, the GHQ-30 excludes items relating to 
physical illness. Although the GHQ-12 is highlighted as a suitable screening 
measure for post-stroke distress (Gillham & Clark, 2011), no validation studies were 
identified in the current review.  
 
One study with a sample of 105 participants was identified as validating the 
GHQ-30 with a stroke population. An optimal cutoff score of at least 9 was 
recommended when screening for any form of psychiatric diagnosis, based upon the 
Schedule for Affective Disorders and Schizophrenia (SADS; Endicott & Spitzer, 
1978).  At 6 months post stroke, the GHQ-30 was found to have an acceptable level 
of sensitivity (0.80) and specificity (0.76), which was comparable to the HADS.  
 
Two studies with a total of 209 participants were identified as validating the 
GHQ-28 with a sample of stroke survivors (Johnson et al., 1995; Lincoln, et al., 
2003). In both studies, the GHQ-28 was shown to meet recommend levels of 
accuracy when detecting depression, as outlined in Table 5.  
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Johnston et al. (1995) evaluated the accuracy of the GHQ-28 in a sample of 
66 stroke survivors 4 months post-stroke. Using a cut-off score of at least 5, the 
GHQ-28 obtained an adequate level of sensitivity (0.89) and specificity (0.75) when 
detecting DSM-III cases of depression. However, the performance of the GHQ-28 
was less satisfactory when detecting anxiety, namely generalised anxiety disorder 
and agoraphobia (sensitivity: 0.71, specificity: 0.56).  
 
In a subsequent study by Lincoln et al. (2003), an optimal cut-off score of at 
least 12 was recommended when detecting ICD-10 cases of depression (sensitivity: 
0.81, specificity: 0.68); whereas an optimal cut-off score of at least 8 was 
recommended when detecting DSM-III-R cases of depression (sensitivity 0.85; 
specificity 0.61).  
 
Table 5 
Stroke Related Cut-Off Scores for the GHQ-28  
Study  Criterion standard  Time since stroke  Cutoff 
        Johnson et al. (1995)  DSM-III depression  4 months  ≥5‡ 
  DSM-III anxiety  4 months  ≥5 
Lincoln et al. (2003)  DSM-III-R depression  Up to 6 months  ≥8‡ 
  ICD-10 depression  Up to 6 months  ≥12‡ 
‡ Cut-off meeting recommended levels of sensitivity (≥0.80) and specificity (≥0.60) 
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Geriatric Depression Scale (GDS-30 and GDS-15) 
 
The GDS (Yesavage et al., 1982) is a 30-item self-report questionnaire based 
upon a yes/no format, developed for detecting depression in older adults. A score of 
0-10 is considered normal, with scores of 11 or more indicating possible depression. 
A shorter version also exists called the GDS-15, where a score of at least 5 indicates 
depression (Sheikh & Yesavage, 1986).  
 
Three studies with a total of 191 participants were identified as validating the 
GDS-30 within stroke (Agrell & Dehlin, 1989; Johnson, et al., 1995; Sivrioglu et al., 
2009). In each study, the GDS-30 met recommended levels of accuracy for a 
screening tool within stroke, as outlined in Table 6.  
 
Agrell and Dehlin (1989) evaluated the accuracy of the GDS-30 at detecting 
major and minor depression in a sample of 40 outpatient stroke survivors. Using a 
cut-off score of at least 10, the GDS-30 met recommended levels of sensitivity (0.88) 
and specificity (0.64). 
 
Johnson et al. (1995) provided evidence for using the standard cut-off score 
of at least 11 to meet recommended levels of accuracy when screening for major and 
minor depression (sensitivity: 0.84; specificity: 0.66). However, when using an 
optimal cut-off score of at least 15, the GDS-30 did not meet recommended levels of 
accuracy when screening for anxiety (sensitivity: 0.65; specificity: 0.79). 
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Sivrioglu et al. (2009) evaluated the accuracy of the GDS-30 at identifying 
minor depression in a population of stroke survivors who had experienced a stroke 
between 17 days and 2 years.  In line with Agrell and Dehlin (1989), a lower cut-off 
score of at least 9 was recommended to meet adequate levels of sensitivity (0.80) and 
specificity (0.61).  
 
Table 6 
Stroke Related Cutoff Scores for the GDS-30  
Study  Time since stroke  Cutoff 
      Agrell and Dehlin (1995)  4ms-2.5 years  ≥10‡ 
Johnson et al. (1995)  4 months  ≥11‡ 
Sivrioglu et al. (2009)  17 days – 2 years  ≥9‡ 
‡ Cut-off meeting recommended levels of sensitivity (≥0.80) and specificity (≥0.60) 
 
Four studies with a total of 507 participants were identified as validating the 
GDS-15 with a stroke population (Lee, Tang, Yu, & Cheung, 2008; Roger & 
Johnson-Greene, 2009; Tang et al., 2004a; Tang et al., 2004b). In two of the four 
studies, the GDS-15 met recommended levels of accuracy for a screening tool in 
stroke, as outlined in Table 7 (Lee, et al., 2008; Tang, et al., 2004a). 
 
Tang et al. (2004a) investigated the accuracy of the GDS-15 with a group of 
127 elderly Chinese stroke survivors within 3 months of having a stroke. The 
accuracy of the GDS-15 was compared to the DSM-IV criteria for major and minor 
depression and dysthmia. A cut-off score of at least 7 was recommended which 
produced an adequate level of sensitivity (0.89) and specificity (0.73).   
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In a second study, Tang et al. (2004b) recommended using an optimal cut-off 
score of at least 6 to detect DSM-III cases of major depression, dysthymia, or 
adjustment disorder in a group of 60 stroke survivors (40-90 years). However, the 
sensitivity (0.64) of the GDS-15 fell short of more recent guidelines (Bennett & 
Lincoln, 2006).  
 
In a large sample (N=253) of Chinese stroke survivors, Lee et al. (2008) 
evaluated the accuracy of the GDS-15 at detecting depression 1 month post-stroke. 
However, in contrast to Tang et al. (2004b), their study offered promising results for 
the GDS-15 when using a standard cut-off score of at least 5 (sensitivity: 0.84, 
specificity: 0.77).  
 
In a more recent and smaller study of stroke survivors (N=67), the GDS-15 
with a cut-off score of at least 3, did not meet recommended levels of sensitivity 
(0.67) and specificity (0.73), despite performing better than the CES-D and Stroke 
Inpatient Depression Inventory (SIDI; Roger & Johnson-Greene, 2008).  
 
Table 7 
Stroke Related Cutoff Scores for the GDS-15  
Study  Time since stroke  Cutoff 
      Tang et al. (2004a)  3 months  ≥7‡ 
Tang et al. (2004b)  ≤1 month  ≥6 
Lee et al. (2008)  1 month  ≥5‡ 
Roger & Johnson-Greene (2009)  Mean: 8 days  ≥3 
‡ Cut-off meeting recommended levels of sensitivity (≥0.80) and specificity (≥0.60)  
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Hospital Anxiety and Depression Scale (HADS) 
 
The HADS (Zigmond & Snaith, 1983) is a 14-item self-report measure. It 
contains two subscales which measure anxiety (HADS-A) and depression       
(HADS-D). The total score (HADS-T) can be used as a measure of emotional 
distress (Herrmann, 1997). According to the manual a sub-scale score of 0-7 is 
considered normal, scores of 8-10 are mild, scores of 11-14  are moderate, and 
scores between 15 -21 are severe.  
 
The HADS was the most frequently validated measure identified in the 
review. Eight studies with a total of 755 participants validated the HADS with a 
stroke population (Aben, et al., 2002; Healey, et al., 2008; Johnson, et al., 1995; 
O'Rourke, MacHale, Signorini, & Dennis, 1998; Sagen, et al., 2009; Tang, et al., 
2004b; Tang, et al., 2004c; Turner, et al., 2012).  
 
All eight studies validated the HADS-D subscale relative to a diagnosis of 
depression. In five studies the HADS-D was found to meet recommended levels of 
accuracy proposed by Bennett and Lincoln (2006). Two out of the five studies 
provided support for using the standard cut-off score of 8 (Healey, et al., 2008; 
Turner, et al., 2012). However, three studies recommended using lower cut-off 
scores, as detailed in Table 8 (O'Rourke, et al., 1998; Sagen, et al., 2009; Tang, et al., 
2004b). Three studies with a total of 375 participants validated the HADS-T against 
a diagnosis of depression, all of which met the recommend levels of accuracy for a 
screening tool in stroke when using a cut-off score of at least 11 (Aben, et al., 2002; 
Sagen, et al., 2009; Turner, et al., 2012).   
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Relative to a diagnosis of anxiety, three studies with a total of 272 
participants validated the HADS-A subscale (Johnson, et al., 1995; O'Rourke, et al., 
1998; Sagen, et al., 2009). The HADS-A met recommend levels of accuracy in two 
out of the three studies, both of which used a cut-off score lower than standard of at 
least 8, as outlined by Table 9 (O'Rourke, et al., 1998; Sagen, et al., 2009). One 
study validated the HADS-T relative to a diagnosis of anxiety disorder, which also 
met recommended levels of accuracy using a cut-off score of at least 6 (Sagen, et al., 
2009). 
 
Johnson et al. (1995) compared the ability of the HADS at detecting DSM-III 
cases of anxiety and depression 4 months post stroke. An optimal cut-off score of at 
least 5 was recommended when using the HADS-D (sensitivity: 0.83, specificity: 
0.44); whereas a cut-off score of least 6 was recommended for the HADS-A 
(sensitivity: 0.80, specificity: 0.46). While sensitivity was good for both subscales, 
specificity was poor. In comparison to the GDS and GHQ-28, the HADS was rated 
the least satisfactory self-report scale.   
 
In contrast, O’Rourke et al. (1998) concluded that the HADS-A and HADS-
D was an acceptable screening tool for anxiety (sensitivity: 0.83, specificity: 0.68) 
and depression (sensitivity: 0.80, specificity: 0.79) at 6 months post-stroke. 
However, as detailed by Johnson et al. (1995), standard cut-off scores were 
suboptimal and a lower score of at least 7 was recommended when screening for 
post-stroke anxiety or depression.   
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Aben et al. (2002, p. 390) evaluated the screening abilities of the HADS to 
detect DSM-IV cases of major and minor depression. Optimal cut-off scores of at 
least 8 on the HADS-D (sensitivity: 0.73, specificity: 0.82), 5 on the HADS-A 
(sensitivity: 0.92, specificity: 0.56) and 11 on HADS-T (sensitivity: 0.92, specificity: 
0.65) identified major depression in a sample of 202 stroke patients 1 month post-
stroke.  While the performance of the HADS was less accurate when screening for 
major and minor depression, this was not “meaningfully” different.  
 
Healey et al. (2008) also provide support for the standard cut-off score of at 
least 8 when screening for depression. The ability of the HADS-D to detect DSM-IV 
cases of major depression met more recent recommendations within stroke 
(sensitivity: 0.86, specificity: 0.69). However, the accuracy of the HADS-D at 
detecting major and minor depression fell below these recommendations (sensitivity: 
0.62, specificity: 0.69).  
 
Tang et al. (2004c) evaluated the screening abilities of the Chinese version of 
the HADS-D with 100 geriatric patients with first time stroke. While an optimal cut-
off score of at least 7 was recommended, specificity was poor (sensitivity: 0.88, 
specificity: 0.53). Due to high rates of false positives, Tang et al. (2004c) concluded 
that the HADS-D was not a useful screening tool for post-stroke depression. When 
lowering the cut-off score to at least 4 in a subsequent study of 60 Chinese stroke 
survivors, Tang et al. (2004b) concluded that the HADS was satisfactory when 
screening for post-stroke depression (sensitivity: 0.86, specificity: 0.78). 
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More recently, Sagen et al. (2009) compared the accuracy of the HADS at 
detecting DSM-IV cases of anxiety and depression in 104 Norwegian stroke patients 
4 months post-stroke. When screening for anxiety or depression, lower cut-off scores 
of at least 4 on both subscales were also recommended to obtain acceptable levels of 
sensitivity (≥0.80) and specificity (≥0.60). Whereas a cut-off score of at least 11 was 
recommended on the HADS-T to detect depression. Similarly, Turner et al. (2012) 
recommended at cut-off score of at least 11 on the HADS-T, however, a standard 
cut-off score of at least 8 on the HADS-D met recommended levels of sensitivity and 
specificity when detecting DSM-IV cases of major depression.  
 
Table 8 
Stroke Related Cut-Off Scores for the HADS Relative to a Diagnosis of Depression 
Study  Subscale  Time since stroke  Cutoff 
        Johnson et al. (1995)  HADS-D  4 months  ≥5 
O’Rourke et al. (1998)  HADS-D  6 months  ≥7‡ 
Aben et al. (2002)  HADS-D  1 month   ≥8 
  HADS-A  1 month  ≥5 
  HADS-T  1 month  ≥11‡ 
Tang et al. (2004c)  HADS-D  3-4 weeks  ≥7 
Tang et al. (2004b)  HADS-D  ≤1 month  ≥4‡ 
Healey et al. (2008)  HADS-D  16-113 days  ≥8‡ 
Sagen et al. (2009)  HADS-D  4 months  ≥4‡ 
  HADS-T  4 months  ≥11‡ 
Turner et al. (2012)  HADS-D  3 weeks-45 years  ≥8‡ 
  HADS-T  3 week-45 years  ≥11‡ 
‡ Cut-off meeting recommended levels of sensitivity (≥0.80) and specificity (≥0.60)  
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Table 9 
Stroke Related Cut-Off Scores for the HADS Relative to a Diagnosis of Anxiety 
Study  Subscale  Time since stroke  Cutoff 
        Johnson et al. (1995)  HADS-A  4 months  ≥6 
O’Rourke et al. (1998)  HADS-A  6 months  ≥7‡ 
Sagen et al. (2009)  HADS-A  4 months  ≥4‡ 
  HADS-T  4 months  ≥6‡ 
‡ Cut-off meeting recommended levels of sensitivity (≥0.80) and specificity (≥0.60) 
 
 
Kessler-10 (K10) 
 
The K10 (Kessler et al., 2002) is a 10-item self-report screening scale of 
psychological distress, developed for the US National Health Interview Survey 
(NHIS). Each item is rated on a 5-point scale from 1 (none of the time) to 5 (all of 
the time) in relation to the past month, with a total score of 50. According to the 
Australian Bureau of Statistics Health Surveys (2008, p. 1), people who score 
between 10-19 “are likely to be well”, 20 -24 “are likely to have mild  levels of 
mental disorder”, 25-29 “are likely to have a moderate mental disorder”, and 30-50 
“are likely to have a severe mental disorder”. 
 
  One study was identified as validating the K10 among 72 stroke survivors. 
Turner et al. (2012) evaluated the accuracy of the K10 at discriminating between 
DSM-IV cases of major depression with a group of Australian stroke survivors.    
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While the standard cut-off score of at least 20 did not meet recommended levels of 
sensitivity and specificity (sensitivity: 0.77, specificity: 0.69), a cut-off score of at 
least 18 almost met this criteria (sensitivity: 0.85, specificity: 0.59). Turner et al. 
(2012) concluded that the K10 could be used as an adequate screening measure for 
major depression among stroke survivors.   
 
Patient Health Questionnaire (PHQ) 
 
The PHQ-9 (Spitzer, Kroenke, Williams, & Group, 1999) is a 9-item self-
report questionnaire designed to screen for depression over the last 2 weeks. Scores 
range from 0 to 27 and are based upon a 4-point multiple choice scale from 0 (not at 
all) to 3 (nearly every day). A cut-off score of at least 10 is recommended within 
primary care. More recently, the PHQ-2 (Kroenke, Spitzer, & Williams, 2003) was 
developed and contains two items from the PHQ-9 which include depressed mood  
and anhedonia . As with the PHQ-9, each item is rated over the last 2 weeks on a 4-
point multiple choice scale. Scores range from 0 to 6. 
 
Three studies with a total of 559 participants were identified as validating the 
PHQ-9 and PHQ-2 amongst a population of stroke survivors (de Man-van Ginkel et 
al., 2012; Turner, et al., 2012; Williams et al., 2005). In each study, the PHQ-9 was 
found to meet recommended levels of accuracy when screening for depression, as 
outlined by Bennett and Lincoln (2006). However, the PHQ-2 was only found to 
meet recommended levels of accuracy in one study which consisted of 316 
participants (Williams, et al., 2005). Please refer to Tables 10 and 11 for a summary 
of recommended cut-off scores.  
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Williams et al. (2005) provided the first study to validate the PHQ-9 and 
PHQ-2 with a sample of 316 stroke survivors at 1 and 2  months post-stroke. When 
using a cut-off score of at least 10, the PHQ-9 demonstrated an adequate level of 
accuracy for major depression and any depressive disorder (sensitivity: 0.91 and 
0.78, specificity: 0.89 and 0.96, respectively). Similarly, when using a cut-off score 
of at least 3, the PHQ-2 had acceptable levels of accuracy for major depression and 
any depressive disorder (sensitivity: 0.83 and 0.78, specificity: 0.84 and 0.94, 
respectively).  However, a major limitation of this study was that the criterion 
standard was only administered to those who scored within the clinical range on the 
PHQ-9 and PHQ-2.  
 
Verification bias of this type can affect both sensitivity and specificity, where 
participants with false negative results go undetected (Whiting, et al., 2004). To 
overcome this limitation, a further two studies were conducted which investigated 
the accuracy of the PHQ-9 and PHQ-2 at discriminating between DSM-IV cases of 
major depression (de Man-van Ginkel, et al., 2012; Turner, et al., 2012). To prevent 
review bias, the clinical interview was completed blind to the results of the PHQ 
(Whiting, et al., 2004).   
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In a group of 171 stroke survivors, the PHQ-9 was found to have an 
acceptable level of accuracy as a screening measure for post-stroke depression 
(sensitivity: 0.80, specificity: 0.78) when using the standard cut-off score of at least 
10 (de Man-van Ginkel, et al., 2012). However, when Turner et al. (2012) evaluated 
the accuracy of the PHQ-9 with a group of stroke survivors between 3 weeks and 45 
years post-stroke, a lower cut-off score of at least 7 was required to meet a similar 
balance of accuracy (sensitivity: 0.85, specificity: 0.63). According to Turner et al. 
(2012), a cut-off score of at least 2 on the PHQ-2 came close to recommended levels 
of accuracy (sensitivity: 0.77, specificity: 0.63). Due to its brevity, the PHQ-2 was 
recommended as the most useful single-item screening tool.   
 
Table 10 
Stroke Related Cut-Off Scores for the PHQ-9  
Study  Time since stroke  Cutoff 
      Williams et al. (2005)  1-2 months  ≥10‡ 
De Man van Ginkel et al. (2011)  5-9 weeks  ≥10‡ 
Turner et al. (2012)  3 weeks – 45 years  ≥7‡ 
‡ Cut-off meeting recommended levels of sensitivity (≥0.80) and specificity (≥0.60) 
 
Table 11 
Stroke Related Cut-Off Scores for the PHQ-2  
Study  Time since stroke  Cutoff 
      Williams et al. (2005)  1-2 months  ≥3‡ 
De Man van Ginkel et al. (2011)  5-9 weeks  ≥2 
Turner et al. (2012)  3 weeks – 45 years  ≥2 
‡ Cut-off meeting recommended levels of sensitivity (≥0.80) and specificity (≥0.60)  
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Smiley 
 
The smiley (Lee, et al., 2008) was developed to screen for post-stroke 
depression. It contains a sad/tearful face, a neutral/flat face and a happy/smiley face. 
Participants are asked to rate the frequency of experiencing these emotions over the 
past week using a 3-point scale from 0 (none at all), 1 (less than half the time in a 
week), and 2 (equal to or more than half the time).  
 
One study was identified as validating the Smiley with 253 Chinese stroke 
patients 1 month post stroke relative to the DSM-IV criteria for depression (Lee, et 
al., 2008). Although the sad face was the most accurate face, sensitivity fell just 
under recommendations (sensitivity: 0.76, specificity: 0.77). The GDS was found to 
be superior.  
 
Stroke Inpatient Depression Inventory (SIDI) 
 
The SIDI (Rybarczyk, et al., 1996) is a 30-item self-report measure of 
depression, rated using a yes/no format. The SIDI was developed specifically for use 
with stroke patients in hospital and contains items unique to this population and 
within the time frame of having had a stroke, such as “are you worrying a great deal 
about how you’re going to get by after you leave the hospital?”  
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Two studies with a combined total of 117 participants were identified as 
validating the SIDI with a sample of stroke survivors (Roger & Johnson-Greene, 
2009; Rybarczyk, et al., 1996). In one out of the two studies the SIDI was found to 
meet recommended levels of diagnostic accuracy (Rybarczyk, et al., 1996). 
 
The SIDI was originally validated with 50 non-aphasic stroke inpatients 
(Rybarczyk, et al., 1996). The SIDI demonstrated good internal consistency 
(Cronbach’s  = 0.90). In relation to the DSM-III criteria for depression, the SIDI 
produced an acceptable level of validity (specificity: 0.94, sensitivity: 0.71). An 
optimal cut-off score of at least 17 was indicated and the SIDI showed precedence 
over the CES-D. However, Roger and Johnson-Greene (2009) provided 
contradictory evidence. While the accuracy of the SIDI continued to be superior to 
the CES-D, a lower cut-off score was advocated (≥10) and the overall accuracy of 
the SIDI performed below recommended levels (sensitivity: 0.66, specificity: 0.72). 
As a result, the GDS-15 was recommended above the SIDI and CES-D.  
 
Symptom Checklist – 90 (SCL-90) 
 
The SCL-90 (Derogatis, Rickels, & Rock, 1976) is a 90-item self-report 
measure designed to measure psychopathology in psychiatric and medical patients 
over the last 7 days. Each item is rated on a 5-point scale of distress from 0 (not at 
all) to 4 (extreme).  
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One study was identified as validating the SCL-90 among a population of 
202 stroke survivors (Aben, et al., 2002). The SCL-90 depression subscale was 
found to have an acceptable level of sensitivity (0.89, 0.88) and specificity (0.61, 
0.66) when detecting DSM-IV diagnoses of major depression and major and minor 
depression 1 month post stroke. An optimal cut-off score of 25 was recommended.  
While the accuracy of the SCL-90 was comparable to the HADS and BDI, the   
SCL-90 was less favorable due to it taking longer to complete.  
 
Visual Analogue Mood Scale (VAMS and VAMS-SAD) 
 
The VAMS (Stern, Arruda, Hooper, & Wolfner, 1997) consists of seven 
10cm vertical lines containing a neutral cartoon face at the top of the line, and one of 
seven cartoon faces at the bottom of the line, depicting sad, afraid, tired, angry, 
confused, happy and energetic. The individual is asked to indicate their current mood 
on the vertical line. The VAMS was created specifically for people who have 
neurological disorders and communication disorders.  
 
One study was identified as validating the VAMS amongst a sample of 100 
stroke survivors relative to the HADS (Bennett, Thomas, Austen, Morris, & Lincoln, 
2006)  While the VAMS correlated significantly with the HADS-T (rs = .45; 
p<.001), HADS-D (rs = .36; p<.001) and HADS-A (rs = .43; p<.001), no suitable 
cut-off scores were identified when screening for depression (sensitivity: 0.81, 
specificity: 0.05) or anxiety (sensitivity: 0.71, specificity: 0.66).  
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In contrast, the authors demonstrated that the one item sad face (VAMS-
SAD) did meet acceptable levels of sensitivity (0.88) and specificity (0.62). 
However, this  finding was not supported by Berg et al. (2009) who investigated the 
accuracy of the VAMS-SAD relative to the DSM-III-R criteria for major depression. 
The accuracy of the VAMS-SAD was evaluated among 100 stroke survivors at 2 
months, 6 months, 12 months and 18 months post-stroke. While the specificity of the 
VAMS-SAD met recommended levels of accuracy, sensitivity (0.60) fell short of 
0.80. 
 
Visual Analogue Self-Esteem Scale (VASES) 
 
The VASES (Brumfitt & Sheeran, 1999) is a self-report visual analogue scale 
of self-esteem. It contains 10 pairs of line drawings which represent opposite 
constructs of the self (cheerful/not cheerful, trapped, optimistic, confident, frustrated, 
confused, misunderstood, outgoing, intelligent and angry). Like the VAMS, the 
VASES was developed specifically for aphasic patients. The pairs of drawings are 
presented one at a time and are scored from 1 to 5. 
 
One study was identified as validating the VASES among a group of stroke 
survivors. Bennett et al. (2006) evaluated the diagnostic accuracy of the VASES at 
detecting post-stroke depression and anxiety with a sample of 100 non-aphasic 
stroke survivors.  While the VASES correlated significantly with both subscales of 
the HADS and total scale, the VASES failed to show acceptable cut-off scores 
(sensitivity: 0.81; specificity: 0.05). 
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Wakefield Depression Inventory (WDI) 
 
The WDI (Snaith, Ahmed, Mehta, & Hamilton, 1971) is a 12-item self-report 
questionnaire designed to measure the severity of depression within a psychiatric 
population. Items are rated on a 4-point scale. The WDI was developed to provide a 
brief and simple measure of depression. A cut-off score of at least 15 was 
recommended in the original study when used with a general population.  
 
One study was identified as validating the WDI with a population of 143 
stroke survivors (Lincoln, et al., 2003). Optimal cut-off scores of at least 19 and 21 
were identified, relative to the ICD-10 and DSM-III criteria respectively. However, 
although the WDI had an acceptable level of sensitivity (0.86 and 0.92), specificity 
was low (0.50 and 0.46).   
 
Yale  
 
The Yale question (Lachs et al., 1990), ‘Do you feel depressed?’, is 
recommended by the National Clinical Guidelines for Stroke when screening for 
depression (Intercollegiate Stroke Working Party, 2008). The Yale was initially 
developed by the Yale Task Force to screen for depression in older patients.  
 
Three studies with a combined total of 315 participants were identified as 
validating the Yale with a population of stroke survivors (Turner-Stokes, et al., 2005; 
Watkins, Daniels, Jack, Dickinson, & van den Broek, 2001; Watkins et al., 2007).   
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In two of the three studies (N=201) the Yale was found to meet 
recommended levels of accuracy (Watkins, et al., 2001; Watkins, et al., 2007). 
 
The Montgomery-Asberg Depression Rating Scale (MADRS; Montgomery 
& Asberg, 1979) is a clinician-rated scale used by two studies as the criterion 
standard. In both studies, the Yale was seen to have good sensitivity (0.86) and 
specificity (0.78 and 0.84 respectively) for detecting depression at 2 weeks post 
stroke (Watkins, et al., 2001; Watkins, et al., 2007). At 3 months post-stroke, the 
accuracy of the Yale improved, with sensitivity and specificity of 0.95 and 0.89 
(Watkins, et al., 2007).   
 
More recently, Turner-Stokes et al. (2005) evaluated the ability of the Yale at 
predicting DSM-IV cases of depression in a younger adult population. The accuracy 
of the Yale question was found to be lower than the above studies (sensitivity 0.68, 
specificity 0.73) and outside recommended levels. In comparison to the DISCS and 
BDI-II, the Yale performed least well.  
 
Zung Self-Rating Depression Scale (ZSDS) 
 
The ZSDS (Zung, 1965) is a 20-item self-report scale developed to identify 
clinically significant depression within a psychiatric population. Items are rated on a 
4-point likert scale over the past few days. A score of at least 55 is used to identify 
depression in people over the age of 60.  
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One study was identified as validating the ZSDS with a sample of 40 stroke 
survivors. Using a lower cut-off score of at least 40, Agrell and Dehlin (1989) 
concluded that the ZSDS was an acceptable screening tool for post-stroke 
depression. The sensitivity (0.76) and specificity (0.96) of the ZSDS was comparable 
to the GDS and superior to the CES-D.  
 
Diagnostic Accuracy  
 
Overall, 24 measures were evaluated as a screening tool for depression. 
Fifteen were found to meet recommended levels of diagnostic accuracy as a 
screening tool for depression, as outlined by Bennett and Lincoln (2006). These 
include the BDI, BDI-II, BASDEC, CES-D, GHQ-30, GHQ-28, GDS-30, GDS-15, 
HADS (including the HADS-D and HADS-T), PHQ-9, PHQ-2, SIDI, SCL-90, 
VAMS-SAD and Yale. However, the standard cut-off score for each measure was 
not always used to meet this balance of accuracy. For example, in one study a higher 
cut-off score of at least 26 was recommended when using the CES-D (Rybarczyk, et 
al., 1996) and in three studies a lower cut-off score of at least 4 and 7 was 
recommended when using the HADS-D (O'Rourke, et al., 1998; Sagen, et al., 2009; 
Tang, et al., 2004b).  
 
Three measures were validated as a screening tool for anxiety, which 
included the BAI, GHQ-28 and HADS (HADS-A and HADS-T). However, the 
HADS-A was the only measure to meet recommended levels of accuracy. This 
finding was supported by two studies, both of which used lower cut-off scores 
compared to the standard of at least 8 (O'Rourke, et al., 1998; Sagen, et al., 2009).  
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Clinical Utility  
 
Length of measure. 
 
The length of each measure was categorised according to three groups 
including ultrashort, short and long measures. Six ultrashort measures consisting of 1 
to 4 items were identified. These included the DISCS , DT, PHQ-2, Smiley, VAMS-
SAD and Yale. Eleven short measures, which consisted of 5 to 20 items were 
identified, namely the BDI-FS, BASDEC, CES-D, GDS-15, HADS, K10, PHQ-9, 
VAMS, VASES, WDI and ZDRS. The remaining eight measures were classed as 
long measures and consisted of at least 21 items. These included the BAI, BDI, BDI-
II, GHQ-28, GHQ-30, GDS-30, SIDI, and SCL-90. 
 
Type of training required to administer each measure. 
 
No specific training is required to use any of the measures identified in the 
review other than reading the manual or original paper where applicable. However, it 
is assumed and stipulated for the BAI, BDI-II, BDI-FS, HADS, GHQ, SCL-90, 
VASES and VAMS that prior training as a healthcare professional or researcher is 
required to administer and interpret each self-report measure.   
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Response format. 
 
Thirteen measures consisted of a multiple choice format. These included the 
BAI, BDI, BDI-II, BDI-FS, CES-D, GHQ-28, GHQ-30, HADS, PHQ-9, PHQ-2, 
SCl-90, WDI and ZDRS. Apart from the SCL-90 which consisted of a 5-point scale, 
the remaining twelve measures were scored on a 4-point scale. Five measures 
consisted of a yes/no format which included the BASDEC, GDS, GDS-15, SIDI and 
Yale. Six measures comprised visual analogue scales and included the DISCs, DT, 
Smiley, VASES, VAMS, and VAMS-SAD. 
 
Sample characteristics. 
 
Nationality of participants. 
Eight studies were carried out in the UK (Bennett, et al., 2006; Healey, et al., 
2008; House, et al., 1989; Lincoln, et al., 2003; O'Rourke, et al., 1998; Turner-
Stokes, Kalmus, Hirani, & Clegg, 2005; Watkins, Daniels, Jack, Dickinson, & van 
den Broek, 2001; Watkins et al., 2007), six studies were carried out in the USA 
(Parikh, et al., 1988; Roger & Johnson-Greene, 2009; Rybarczyk, et al., 1996; 
Schramke, et al., 1998; Shinar, et al., 1986; Williams, et al., 2005), four studies were 
carried out in China (Lee, et al., 2008; Tang, et al., 2004a; Tang, et al., 2004b; Tang, 
et al., 2004c), two studies were carried out in Australia (Johnson, et al., 1995; 
Turner, et al., 2012) and the Netherlands (Aben, et al., 2002; de Man-van Ginkel, et 
al., 2012), and one study was carried out in Finland (Berg, et al., 2009), Norway 
(Sagen, et al., 2009), Sweden (Agrell & Dehlin, 1989), and Turkey (Sivrioglu, et al., 
2009).   
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Sixteen studies recruited English speaking participants. Of the 25 measures 
identified in the review, only 3 measures were not validated amongst a sample of 
English speaking stroke survivors. These include the Smiley, SCL-90 and ZSRDS.  
 
Study setting. 
Thirteen studies were conducted within inpatient settings, such as specialist 
stroke units and/or rehabilitation units (Aben, et al., 2002; Bennett, et al., 2006; 
Healey, et al., 2008; Lee, et al., 2008; Roger & Johnson-Greene, 2009; Rybarczyk, et 
al., 1996; Sagen, et al., 2009; Tang, et al., 2004a; Tang, et al., 2004b; Tang, et al., 
2004c; Turner-Stokes, et al., 2005; Watkins, et al., 2001; Williams, et al., 2005). In 
contrast, six studies recruited participants from community settings, such as support 
groups, hospital discharge registers, outpatient clinics, day hospitals, nursing homes, 
and community stroke teams (Agrell & Dehlin, 1989; de Man-van Ginkel, et al., 
2012; House, et al., 1989; Johnson, et al., 1995; O'Rourke, et al., 1998; Schramke, et 
al., 1998). Seven studies recruited participants from both inpatient and community 
based settings (Berg, et al., 2009; Lincoln, et al., 2003; Parikh, et al., 1988; Shinar, et 
al., 1986; Sivrioglu, et al., 2009; Turner, et al., 2012; C. L. Watkins, et al., 2007).  
 
Of the 25 measures identified 13 were validated amongst stroke survivors 
within inpatient and community settings. These included the BDI, BDI-II, CES-D, 
DT, GHQ-28, GDS-30, HADS, K-10, PHQ-9, PHQ-2, VAMS-SAD, WDI and Yale. 
Nine measures were validated amongst stroke survivors within inpatient settings 
only. These included the BDI-FS, BASDEC, DISCs, GDS-15, Smiley, SIDI, SCL-
90, VAMS, and VASES.  Moreover, three measures, the BAI, GHQ-30 and ZSRDS, 
were only validated amongst stroke survivors within community settings.  
64      VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS 
  Time since stroke. 
  The time between onset of stroke and the completion of the mood assessment 
varied between studies and ranged from 3 days (Rybarczyk, et al., 1996) to 45 years 
(Turner, et al., 2012). Twenty two studies were carried out using a cross-sectional 
design, whereas three studies followed the same sample of participants over a period 
of time and reported follow-up data for the BDI (Berg, et al., 2009; House, et al., 
1989), VAMS-SAD (Berg, et al., 2009), and Yale (Watkins, et al., 2007).  
 
Exclusion criteria. 
All of the studies identified in the review excluded participants who had 
cognitive and communication problems which would hinder the completion of a 
clinical interview and self-report measure. Various other exclusion criteria were 
reported, which included comorbid conditions (such as dementia, psychosis, and 
Parkinson’s Disease), the use of antidepressant medication, and being over the age of 
70 years. 
 
Cost of purchasing measure.  
 
Twelve measures are available in the public domain and free to use for 
clinical purposes with and without the express written permission from the authors, 
as detailed in Table 12. Eleven measure are protected by copyright and can be 
purchased for a fee. The availability of the Smiley is unknown as the authors did not 
specify whether the measure could be purchased for clinical use and the BDI is out 
of print due to being revised as the BDI-II.  
  
VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS      65 
Table 12 
Cost and Availability of Each Measure 
Measure  Cost 
BAI  Manual and 25 record forms $120.00 from 
www.pearsonassessments.com/pai/ca/cahome.htm 
BDI  Out of print 
BDI-II  Manual and 25 record forms $120.00 from 
www.pearsonassessments.com/pai/ca/cahome.htm 
BDI-FS  Manual and 50 record forms $99.00 from 
www.pearsonassessments.com/pai/ca/cahome.htm 
BASDEC  £9.99 from Amazon and Ebay 
CES-D  Freely available from http://java2.bmedreport.netdna-cdn.com/wp-
content/uploads/2009/11/CES-D-Standford-Version.pdf  
DISCs  Freely available from www.csi.kcl.ac.uk/files/DISCS.pdf 
DT  Free with the express written permission of the NCCN. License obtained from 
www.nccn.org/clinical.asp 
GHQ  Manual £95 and 25 record forms £65 from http://www.gl-assessment.co.uk/ 
GDS-30  Freely available from https://www.outcometracker.org/library/GDS.pdf 
GDS-15  Freely available from www.chcr.brown.edu/GDS_SHORT_FORM.PDF  
HADS  Manual and 100 record forms £95 from http://www.gl-assessment.co.uk/ 
K-10  Freely available from www.gpcare.org/outcome%20measures/outcomemeasures.html 
PHQ-9  Freely available from http://www.phqscreeners.com/ 
PHQ-2  Freely available from http://www.cqaimh.org/pdf/tool_phq2.pdf 
Smiley  Availability of measure not reported 
SIDI  Free with the permission of the author and available from the original article 
SCL-90  Manual and 50 record forms $114.70 from 
http://psychcorp.pearsonassessments.com/pai/ca/cahome.htm 
VAMS   Manual, 25 response forms and metric ruler $144 from  
www4.parinc.com/Products/Product.aspx?ProductID=VAMS# 
VASES  CD ROM and booklet £55.99 + VAT from 
www.speechmark.net/vases-visual-analogue-self-esteem-scale 
WDI  Freely available from the original article 
Yale  Freely available  
ZSRDS  Freely available from 
http://healthnet.umassmed.edu/mhealth/ZungSelfRatedDepressionScale.pdf  
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Discussion 
 
Summary of Main Findings 
 
The aim of this review was to investigate the validity and clinical utility of 
self-report screening measures for the identification of post-stroke distress. In 
conclusion, 25 self-report screening measures were identified as meeting the search 
criteria, based upon the results of 26 studies.  
 
Twenty four measures were evaluated as screening measures for the detection 
of post-stroke depression. In contrast, only three measures were evaluated for the 
detection of post-stroke anxiety. The HADS-A was the only measure to meet 
recommended levels of accuracy for post-stroke anxiety, whereas 15 measures met 
recommended levels of accuracy for post-stroke depression.  As identified by a 
previous review (Bennett & Lincoln, 2006), there is a clear need to develop and 
validate screening measures which can accurately detect post-stroke anxiety. This is 
important as anxiety disorders are thought to be just as prevalent as post-stroke 
depression and are associated with reduced functional outcome and quality of life 
following stroke (De Wit, et al., 2008; Shimoda & Robinson, 1998).  
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Implications for Clinical Practice 
 
While national guidelines (Intercollegiate Stroke Working Party, 2008) 
highlight the importance of mood screening, they do not specify which measure 
should be used to do this. In the current review, it was difficult to identify one 
measure above another due to methodological variation between studies, such as 
varying sample sizes, criterion standards, and clinical characteristics. Furthermore, 
the majority of measures were not originally designed to screen for distress among 
stroke survivors. Consequently, cut-off scores often varied from the standard.  It is 
possible that this variability reflects the heterogeneous nature of stroke and supports 
the idea that local service providers need to choose measures and cut-off scores 
which have been validated most closely with the clinical population at hand.  
 
Service providers also need to take into account the clinical utility of each 
measure. When screening patients on busy medical wards, validated measures are 
needed which are quick and easy to use (Lincoln, et al., 2012). While ultrashort 
measures such as the PHQ-2 and Yale may be quick to use, they do not screen for 
multiple domains of distress. In contrast, short and long measures, such as the HADS 
and GHQ-28 can be used to screen for anxiety and depression and arguably offer a 
greater richness of information but take longer to complete (Vodermaier, et al., 
2009).  
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The generalisation of the current findings to people with moderate to severe 
cognitive and communication difficulties is limited. All of the studies identified in 
the review excluded people with moderate to severe cognitive and communication 
difficulties.  Nonetheless, stroke survivors with aphasia are thought to be at a greater 
risk of developing clinical levels of distress (Barker-Collo, 2007). Consequently, 
future research is needed which evaluates self-report screening measures with stroke 
survivors who have cognitive and communication difficulties based upon observer-
rated criterion standards. 
 
Arguably, the visual analogue scale is thought to be more appropriate for 
people with communication difficulties (Benaim, et al., 2004).  In the current review 
the VAMS-SAD was the only visual analogue scale to meet recommended levels of 
accuracy when detecting depression and this finding was based upon one study 
which excluded aphasic stroke survivors. It is also argued that a consistent and 
simple response format, such as yes/no, may be more beneficial for people with 
cognitive and communication difficulties compared to varying multiple choice 
formats  (Bennett & Lincoln, 2006). Consequently, measures such as the BASDEC, 
GDS, SIDI and Yale may be more preferable when screening someone with reduced 
communication.  
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Limitations of the Review 
 
It was outside the scope of this review to compare and contrast the positive 
and negative predictive values of each measure (Appendix B). The PPV indicates the 
probability of someone experiencing anxiety and depression when the test index is 
positive. However, this is affected by the prevalence of the condition in the study. 
Consequently, when generalising findings to clinical populations, it is important for 
service providers to re-calculate positive and negative predictive values according to 
base rates of anxiety and depression in the clinical population. As the prevalence 
rates of anxiety or depression increase, the PPV value will also increase 
(Baldessarini, Finklestein, & Arana, 1983). 
 
Implication for future research  
 
At the commencement of this thesis, the DT had not been validated among 
stoke survivors, despite being  recommended by NICE (2009) for the identification 
of depression in adults with chronic physical health problems and significant 
communication difficulties. While the diagnostic accuracy of the DT as a screening 
tool for post-stroke depression has been evaluated more recently by Turner et al. 
(2012), its ability to detect post-stroke anxiety has not been investigated. As detailed 
above, there is a need to validate self-report screening measures for the detection of 
post-stroke anxiety. Furthermore, the current review highlights the importance of 
validating measures with stroke survivors to ascertain whether standard cut-off 
scores meet diagnostic accuracy. As an ultra short visual analogue scale, the DT 
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Abstract 
 
Post-stroke distress is common and can range from clinical levels of 
depression and anxiety to less intense and persistent states of emotional adjustment. 
National guidelines recommend that everyone should be screened for mood 
disturbances within six weeks of having a stroke. However, screening measures are 
not well validated among stroke populations. Thirty-one stroke survivors completed 
the Distress Thermometer (DT) and Problem List (PL), Brief Assessment Schedule 
Depression Cards (BASDEC), Yale, and Hospital Anxiety and Depression Scale 
(HADS). Receiver operating characteristic (ROC) analysis was carried out to 
investigate the accuracy of the DT, BASDEC and Yale at identifying clinical cases 
relative to the HADS. The area under the curve (AUC) for the DT (0.74, 0.86) was 
significantly greater than an AUC of 0.50. Cut-off scores of at least 4 and 5 on the 
DT met recommended levels of sensitivity (≥0.80) and specificity (≥0.60). The AUC 
for the BASDEC and Yale were not significantly different to an AUC of 0.50. Due 
to a small sample size, these results should be taken with caution. However, this 
study provides preliminary evidence to support the use of the DT and PL as a holistic 
and person-centred screening tool for the prevention and recognition of post-stroke 
distress.     
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Introduction 
 
Emotional distress is common in many areas of physical illness or injury 
including stroke (Kennedy, 2007). Distress has been defined within cancer patients 
as: 
a multifactorial unpleasant emotional experience of a psychological 
(cognitive, behavioral, emotional), social, and/or spiritual nature that may 
interfere with the ability to cope effectively with cancer, its physical 
symptoms and its treatment. Distress extends along a continuum, ranging 
from common normal feelings of vulnerability, sadness, and fears to 
problems that can become disabling, such as depression, anxiety, panic, 
social isolation, and existential and spiritual crisis (National Comprehensive 
Cancer Network [NCCN], 2003, p. DIS-2). 
 
Depression and to a lesser extent anxiety are the most frequently researched 
areas of post stroke distress (Carney & Freedland, 2002; Intercollegiate Stroke 
Working Party, 2008). Approximately one third of people will experience depression 
within five years of having a stroke (Hackett, Yapa, Parag, & Anderson, 2005) and 
around a quarter of stroke survivors are thought to experience symptoms of 
generalised anxiety (De Wit et al., 2008). As with other long-term physical health 
conditions (Naylor et al., 2012), post-stroke distress has been associated with poorer 
quality of life and reduced physical outcome (Jaracz, Jaracz, Kozubski, & 
Rybakowski, 2002; Pohjasvaara, Vataja, Leppävuori, Kaste, & Erkinjuntti, 2001).  
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As a result, increasing attention is being paid to the “human and economic” 
cost of supporting people with comorbid mental and physical health difficulties. A 
recent report by the King’s Fund highlighted the importance of providing a more 
integrative health system, which would encourage a holistic view of mental and 
physical health care needs. The detection of mental health difficulties is highlighted 
as the first step in supporting this process (Naylor, et al., 2012, p. 22).    
 
Mood Screening 
 
The National Clinical Guideline for Stroke (Intercollegiate Stroke Working 
Party, 2008) recommends that all patients entering rehabilitation and thereafter 
should be screened for depression and anxiety using a validated measure. However, 
“practitioner and system related” factors, such as reluctance to ask sensitive 
questions, time pressure, lack of knowledge and poor awareness of guidelines 
continue to prevent screening (Cully & Stanley, 2008, p. 234; Hammond, O'Keeffe, 
& Barer, 2000; Hart & Morris, 2008).  
 
The detection of post-stroke distress is further complicated due to the 
majority of stroke survivors having an impairment in at least one cognitive domain, 
which may hinder the completion of self-report assessments (Leśniak, Bak, Czepiel, 
Seniów, & Członkowska, 2008). Furthermore, 75% of stroke survivors fall within 
the older adult population (National Audit Office, 2005). The older adult population 
are more likely to report somatic symptoms of distress, which may be misconstrued 
as physical or environmental consequences of stroke, and vice versa (Laidlaw & 
Knight, 2008; Roger & Johnson-Greene, 2009).     VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS      91 
Consequently, measures are needed which are easy to use, require minimal 
training and resources, are accessible in a variety of settings, and take into account 
the somatic overlap of symptoms (Lincoln, Kneebone, Macniven, & Morris, 2012). 
Although a number of brief self-report mood screening measures exist, the majority 
have been developed with healthy working age adults or psychiatric populations 
(Antony, Orsillo, & Roemer, 2001) . As identified in the associated literature review, 
standard cut-off scores are often suboptimal when used with stroke survivors.  
 
Person-Centred Assessment of Need  
 
The International Classification of Functioning, Disability, and Health’s 
(ICF) biopsychosocial model highlights a “dynamic interaction” between a health 
condition, functioning, disability, and contextual factors (WHO, 2001, p. 26). 
Furthermore, the experience and severity of post-stroke distress is likely to vary 
according to the personal meaning that someone attributes to their condition and 
associated disability (Wade & Halligan, 2003). Consequently, post-stroke distress is 
not seen as a single entity but viewed within a holistic framework of someone’s 
subjective needs.  
 
While there is a clear need to validate self-report measures which can 
accurately screen for mood disorders (Intercollegiate Stroke Working Party, 2008), 
many stroke survivors may experience less intense and persistent states of distress 
which still affect quality of life and outcome (House, Knapp, Bamford, & Vail, 
2001). Measures which assess distress along a continuum of severity are required to 
support current needs and prevent escalating difficulties (Kessler et al., 2002).  
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Furthermore, it seems important to recognise factors associated with post-stroke 
distress in order to prevent escalating problems and tailor interventions to the 
person’s specific needs (Hilari et al., 2010). 
 
Factors Associated with Post-Stroke Distress  
 
Over the years, a number of biological and psychosocial factors have been 
implicated in the development of post-stroke distress. Early research suggests that 
post-stoke depression was caused by neurological damage and lesion location 
(Castillo, Starkstein, Fedoroff, & Price, 1993; Robinson, Starr, Kubos, & Price, 
1983). However, a more recent review of the literature disputed such claims and 
current interest has turned to the size of the lesion as opposed to its location (Carson 
et al., 2000; Santos et al., 2009).   
 
In contrast, psychosocial explanations suggest that the development of post-
stroke distress is related to a process of adjustment (Jenkins, Andrewes, Hale, & 
Khan, 2009). Adjustment has been defined as a “fluid process” where emotional 
difficulties can arise as the person learns to adapt and accommodate to change 
(Brennan, 2001; Taylor, Todman, & Broomfield, 2011, p. 809). Early stage models 
have likened post-stroke adjustment to a process of bereavement, initially 
characterised by shock, confusion, and anxiety, followed by a sense of high 
expectations, denial, and grief. As treatment progresses, the person is thought to 
acquire a realisation of their disability, particularly after being discharged home 
(Barton, 2007; Wade, Langton Hewer, Skilbeck, & David, 1985).  
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A more recent model of adjustment by Ch’Ng, French and Mclean (2008) 
suggests that within the acute phase of recovery emotional distress is likely to relate 
to the management of physical and communication problems, loss of control over 
personal care, dissatisfaction with the hospital environment, and uncertainty and 
confusion about what has happened. During the rehabilitation stage, uncertainty 
about prognosis, social isolation and anxiety over the amount of recovery become 
predominant, whereas discharge home is seen to be the most challenging time 
periods, with a sense of abandonment dominating concerns. From this stage 
onwards, distress is thought to be associated with feelings of anger and frustration 
around the loss of future plans and negative views of the self.  
 
Stage models of adjustment suggest that the assessment and treatment of 
emotional distress is likely to differ depending upon the stage of recovery someone 
is in (Lincoln, et al., 2012). The Social Cognitive Transition Model for Stroke 
(SCoTS) however provides a more individualised theory where pre and post injury 
personal characteristics, such as attributions, coping styles, social support, and 
cognitive deficits are emphasised. Unlike stage models of adjustment, the SCoTS 
highlights a cyclical process with no set time frame or right or wrong way to adjust 
(Taylor, et al., 2011). 
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Local Protocols 
 
Self report measures do not facilitate change by themselves (Carlson, Waller, 
& Mitchell, 2012). It is recommended that mood screening measures are used within 
the first level of a stepped care approach to psychological care, from which more 
detailed assessments are used to tailor interventions to the person’s specific needs 
(Carlson, et al., 2012; Gillham & Clark, 2011).  It is recommended that local service 
providers develop mood assessment pathways which take into account the specific 
needs and demographic characteristics of the patient population at hand 
(Intercollegiate Stroke Working Party, 2008).  A primary aim of this study was to 
evaluate the validity of four self-report screening tools, three of which were already 
being used on an acute and sub-acute stroke unit.  
 
As detailed in the associated literature review, the Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983) is one of the most frequently 
validated measures used within stroke services for people without communication 
difficulties (Lincoln, et al., 2012). The HADS is also one of the few measures to 
meet recommended guidelines as a screening tool for post-stroke anxiety in addition 
to depression (O'Rourke, MacHale, Signorini, & Dennis, 1998; Sagen et al., 2009).  
 
The Brief Assessment Schedule Depression Cards (BASDEC; Adshead, 
Cody, & Pitt, 1992) has also demonstrated a high level of sensitivity and specificity 
as a screening tool within stroke. However, evidence of diagnostic accuracy is 
limited to one study and requires replication (Healey, Kneebone, Carroll, & 
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On busy medical wards, there is a preference for ultrashort measures of 
distress. The one-item Yale question (Lachs et al., 1990) is currently being used as a 
first line approach as a screening tool for depression on the stroke unit affiliated with 
this study (Appendix D).  
 
The Distress Thermometer (DT; Roth et al., 1998) is a one-item visual 
analogue scale measuring general distress.  Although research suggests that many 
stroke survivors are unable to use visual analogue scales (Price, Curless, & Rodgers, 
1999), they offer the only form of self assessment for people with communication 
difficulties (Benaim, Cailly, Perennou, & Pelissier, 2004). The DT has been 
validated widely within oncology, with the HADS being used most frequently as the 
criterion standard (Vodermaier, Linden, & Siu, 2009). However, at the 
commencement of this study the DT had not been validated within stroke. This was 
despite the DT being recommended by NICE (2009) for the identification of 
depression in adults with chronic physical health problems and significant 
communication difficulties.  
 
In 2003, the NCCN developed a Distress Management Screening Measure 
(DMSM) which consisted of the DT and an accompanying Problem List (PL). The 
PL is a 38-item list consisting of a yes/no format. It was designed to identify factors 
contributing to emotional distress rated on the DT. It contains five domains including 
practical, family, physical, emotional and spiritual problems. The individual is asked 
to state whether any of the problems have been a problem for them in the last week. 
The PL can be adapted for clinical use (Jacobsen et al., 2005; Vitek, Rosenzweig, & 
Stollings, 2007). While Turner et al. (2012) have recently evaluated the DT as a  
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screening tool for post-stroke depression, the accuracy of the DT as a screening tool 
for post-stroke anxiety has not been investigated. Moreover, the clinical utility of the 
PL in combination with the DT has not been investigated among stroke survivors. 
Unlike other self-report screening tools, the DT and PL offer a more holistic view of 
distress in addition to screening for clinical levels of affective disorders. The PL is 
designed to provide a person-centred assessment of need and assist professionals in 
making appropriate referrals by discussing the associated problems faced by the 
patient and signposting them to appropriate services. Furthermore, the visual 
analogue format and yes/no response of the PL are thought to be more accessible to 
those with cognitive and communication difficulties (Goebel & Mehdorn, 2011).  
 
Rationale and Aims of Study 
 
The National Stroke Strategy (Department of Health [DOH], 2007) 
highlights the importance of providing emotional support throughout the stoke care 
pathway. Although 80% of patients are now being screened for mood disturbance 
within 6 weeks of having a stroke, many stroke survivors continue to have unmet 
needs and experience a lack of emotional and psychological support  (Healthcare 
Commission, 2006).  There is a need to develop and validate screening measures to 
improve the detection, prevention and treatment of post-stroke distress. Stroke 
services also need to provide “a multidisciplinary person-centred assessment” of 
need and signposting to other services (DOH, 2007, p. 45). The DT and PL are being 
piloted on the stroke unit to offer a more unified and holistic approach, which 
addresses the need to screen for clinically significant mood disorders, to assess 
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Consequently, the aim of this study was to evaluate the ability of the DT, 
BASDEC and Yale to screen for post-stroke distress by comparing scores against the 
HADS. Notably, the study was not evaluating the ability of these three measures to 
diagnose psychiatric mood disorders and therefore did not attempt to compare results 
against a structured clinical interview.  
 
Research Questions 
 
1.  Is the PL clinically appropriate for people who have experienced a stroke? 
2.  Is the DT and PL a reliable and valid measure of distress for people who have 
experienced a stroke? 
a.  Will scores on the DT, BASDEC and Yale significantly correlate with 
scores on the HADS, or in other words demonstrate good concurrent 
validity relative to the HADS?  
b.  Will the PL demonstrate internal consistency?  
3.  What cut-off scores on the DT correctly identify distressed cases? 
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Method 
 
Design 
 
A cross sectional, test-criterion design was used.  The test variables were the 
DT, BASDEC and Yale. The criterion variables were the depression subscale of the 
HADS (HADS-D), the anxiety subscale of the HADS (HADS-A), and the total score 
on the HADS (HADS-T).  
 
Participants 
 
Participants consisted of an opportunity sample recruited from an inpatient 
rehabilitation unit for stroke survivors and four charity support groups affiliated with 
The Stroke Association and Headway. Recruitment took place over five months from 
December 2011 to May 2012. Participants were excluded if they had not experienced 
a stroke or transient ischemic attack (TIA), were medically unstable, under the age of 
18 years, were unable to give informed consent (indicated by consultation with the 
stroke team and charity representatives and a score of less than 20 on the MoCA), 
experienced comorbid dementia, had dysphasia that would hinder completion of the 
questionnaires (based upon consultation with the Speech and Language Therapist 
and charity representatives) or were non-English speaking.  
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Measures 
 
The BASDEC (Adshead, et al., 1992) is a self-report measure originally 
developed to screen for depression with geriatric medical inpatients. It consists of 19 
cards each containing a statement derived from the depression scale of the Brief 
Assessment Schedule (BAS-DEP; Ramsay, Wright, Katz, Bielawska, & Katona, 
1991). The client is asked to place each statement next to a true or false card based 
upon their current feelings. A cut off score of at least 7 is used to indicate possible 
depressive disorder (Adshead, et al., 1992; Healey, et al., 2008). Among stroke 
survivors, the BASDEC has been shown to have acceptable internal consistency 
(Kuder-Richardson Formula 20 = 0.77) and test-retest reliability (τ (43) = 0.66, p 
0.001) and good concurrent validity (sensitivity: 1.0, specificity: 0.95; Healey, et al., 
2008, p. 534).  
 
The DT (Roth, et al., 1998) is a one-item self-report scale recommended for 
use as a distress screening tool within cancer services (NCCN, 2011).  It consists of 
an 11-point visual analogue scale, measuring distress from 0 (no distress) to 10 
(extreme distress) during the past week (Figure 1). The DT has demonstrated an 
adequate level of sensitivity (0.89) and specificity (0.60) when detecting symptoms 
of depression or anxiety among patients with intracranial tumours (Goebel & 
Mehdorn, 2011). A cut-off score of at least 4 is recommended by the NCCN as 
warranting further assessment.  
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The PL consists of 38-items based upon a yes/no format. The PL was 
designed to identify factors contributing to distress by working as a semi-structured 
interview where the individual is asked to indicate which items have been a problem 
for them in the past week. This information is used to signpost patients to other 
services and help tailor person-centred interventions (NCCN, 2011).  The PL has 
been found to have a good level internal consistency (Cronbach’s α = 0.81; 
Hoffman, Zevon, D'Arrigo, & Cecchini, 2004). For the purpose of this study, the PL 
was adapted for use with people who have experienced a stroke. This was based 
upon the results of a focus group, literature review, and pilot phase (as detailed 
below). The adapted PL contains 41-items divided into six domains (Figure 2). 
Written permission was obtained from Dr Jimmie Holland, Head of the NCCN 
Distress Management panel, to use the DT and PL (Appendix E).  
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Figure 1. Distress Thermometer.  
 
 
 
Distress Thermometer and Problem List 
 
Instructions: First, please circle the number (0-10) that best describes how 
much distress you have been experiencing in the past week including 
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Figure 2. Adapted Problem List 
Practical Problems                   YES     NO 
Care arrangements       
Child care         
Driving/transportation       
Home environment       
Leaving hospital       
Money/insurance       
Treatment decisions       
Work           
Hobbies         
Comments:____________________________ 
______________________________________ 
 
Family concerns             YES      NO 
Children         
Partner/carers         
Pets           
Ability to have children     
Family health issues       
Comments:____________________________ 
______________________________________ 
 
 
Emotional Problems           YES     NO 
Anger           
Depression         
Fears           
Nervousness         
Sadness         
Worry           
Loss of interest in       
usual activities 
Comments:____________________________  
 
Physical Problems                   YES     NO 
Appearance         
Communication        
Continence         
Dizziness         
Eating/Drinking        
Fatigue          
Mobility          
Muscle weakness       
Nausea          
Pain           
Sexual           
Sleep           
Swallowing         
Tingling in hands/feet       
Vision           
Washing/dressing       
Comments:____________________________ 
______________________________________ 
 
 
Spiritual/religious        
concerns 
Comments:___________________________
_  
 
 
Thinking problems            YES      NO 
Confusion         
Concentration         
Memory          
Comments:____________________________ 
______________________________________ 
 
Second, please indicate if any of the following has been a problem for you in the past week 
including today. Be sure to check YES or NO for each.  
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The HADS (Zigmond & Snaith, 1983) is a 14-item self-report measure. It 
contains two subscales measuring generalised anxiety (HADS-A) and depression 
(HADS-D). The total score (HADS-T) can be used as a measure of emotional 
distress (Herrmann, 1997). It was designed for use with medical patients and has 
been recommended as a mood screening tool for stroke survivors without 
communication difficulties (Bennett & Lincoln, 2006). According to the manual, 
scores of 0-7 are considered normal, scores of 8-10 indicate mild levels of anxiety or 
depression, scores if 11-14 indicate moderate levels of anxiety or depression and 
scores of 15-21 indicate severe levels of anxiety or depression (Snaith & Zigmond, 
1994). However, cut-off scores lower than a score of at least 8 have been 
recommended when screening for post-stroke distress (O'Rourke, et al., 1998; Sagen, 
et al., 2009; Tang, Ungvari, Chiu, & Sze, 2004b) . Nonetheless, the HADS-A 
(Cronbach’s  = .89), HADS-D (Cronbach’s  = .83), and HADS-T         
(Cronbach’s  = .91) have demonstrated good levels of internal consistency and 
acceptable levels of sensitivity and specificity when using a lower cut-off score 
among stroke survivors (Sagen, et al., 2009).   
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The Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) was 
developed as a brief cognitive screening tool to detect mild cognitive impairment 
(MCI)  in patients who performed within the normal range on the Mini Mental State 
Examination (MMSE; Folstein & Luria, 1973). It consists of a 30-point test which 
takes about 10 minutes to administer and measures visual spatial abilities, short-term 
memory, executive functions, attention, working memory, language and orientation. 
The MoCA has demonstrated good internal consistency (Cronbach’s  = .83) and 
test-retest reliability (r = .92) with a sample of elderly patients with and without MCI 
or Alzheimer’s disease.  Based upon a cut-off score of at least 26, the MoCA was 
found  to  have  good  sensitivity  (0.90)  and  specificity  (0.87)  for  detecting  MCI 
relative  to  a  comprehensive  neuropsychological  assessment  (Nasreddine,  et  al., 
2005). When detecting post stroke cognitive impairment, a lower cut-off score of at 
least 20 was highlighted as providing better sensitivity (0.67) and specificity (0.90; 
Godefroy et al., 2011).  The National Clinical Guideline for Stroke (Intercollegiate 
Stroke Working Party, 2008) recommends that every patient who has experienced a 
stroke  or  transient  ischemic  episode  (TIA)  should  be  screened  for  cognitive 
impairment using a standardised measure. As a result, the MoCA is routinely used 
on the stroke unit associated with the current study. 
 
The Yale (Lachs, et al., 1990), “Do you often feel sad or depressed?”, is 
recommended by the National Clinical Guideline for Stroke (Intercollegiate Stroke 
Working Party, 2008). The Yale forms part of the stroke unit mood assessment 
pathway and has been adapted to include two questions: “Prior to your stroke, have 
you often felt sad or depressed” (Yale Q1); “Since your stroke, have you often felt 
sad or depressed” (Yale Q2).   
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The Yale has been validated among stroke survivors and found to have an accurate 
level of sensitivity (≥0.80) and specificity (≥0.60) when screening for depression at 2 
weeks and 3 months post-stroke (Watkins et al., 2007).   
 
Procedure 
 
Focus group. 
 
An opt-in approach was used to recruit participants for the focus group. 
Information packs containing an invitation letter, information sheet, consent form, 
and stamped addressed envelope were handed out at a multidisciplinary team 
meeting on the stroke unit and to a co-ordinator from Headway (Appendix F). Once 
the completed consent forms had been returned, the author arranged a convenient 
time and place to hold the focus group.  
 
The focus group consisted of seven members and two facilitators, including a 
consultant clinical psychologist, charity co-ordinator/occupational therapist from 
Headway, medical consultant, occupational therapist, nurse, physiotherapist, stroke 
survivor affiliated with Headway, trainee clinical psychologist (author and 
facilitator) and clinical psychologist (supervisor and facilitator). Experience of 
working within stroke services ranged from 3 years to 35 years. The original PL, as 
presented in the 2011 NCCN guidelines (Appendix G), was emailed to each member 
prior to the focus group.  The focus group lasted for 90 minutes and used the first 
four stages from the nominal group technique to promote a shared discussion 
(Appendix H; Gallagher, Hares, Spencer, Bradshaw, & Webb, 1993).              VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS      107 
Members were asked to state which items they would keep, omit and add to the PL 
to meet the needs of someone who had experienced a stroke. Lunch was provided 
after the group as a means of saying thank you. The focus group was audio recorded 
and discussions were recorded onto a flipchart (Appendix I).  
 
Literature review. 
 
A review of the literature identified a number of possible predictors and 
associated factors of post-stroke distress, which supported the focus group results. 
These included impaired cognition and communication (Ayerbe, Ayis, Rudd, 
Heuschmann, & Wolfe, 2011; Thomas & Lincoln, 2008), increased stroke severity 
and low activity levels (Ayerbe, et al., 2011), physical disability and reduced 
activities of daily living (Thomas & Lincoln, 2008), inability to work (Ayerbe, et al., 
2011), loneliness and low satisfaction with social support (Hilari, et al., 2010),  lack 
of family support and carer distress (Klinedinst et al., 2009), spirituality and 
religiousness (Giaquinto, Spiridigliozzi, & Caracciolo, 2007), premorbid depression, 
poor satisfaction with treatment and perceived confidence in recovery (Morrison, et 
al., 2000), fatigue (Naess, Lunde, Brogger, & Waje-Andreassen, 2012), pain 
(Lundström, Smits, Terént, & Borg, 2009) and sexual dysfunction (Calabrò, Gervasi, 
& Bramanti, 2011). The Subjective Disability Depression Questionnaire (SDDQ; 
Jenkins, et al., 2009), National Clinical Guideline for Stroke (Intercollegiate Stroke 
Working Party, 2008), and the ICF Core Set for Stroke (Geyh et al., 2004) also 
highlighted a range of physical, psychological and social problems which may 
increase post-stroke distress. For the purpose of this study, each item on the adapted 
PL was cross referenced with the ICF Core Set for Stroke (Appendix J).  
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Pilot study. 
 
The author attended a Stroke Association support group. Five stroke 
survivors were shown the adapted PL and asked to comment on the clarity and 
content of the PL. As a result of this process, a few minor changes were made to the 
layout and wording of the PL. However, in general the PL was found to be 
acceptable and easy to complete.   
 
Validation study. 
 
Inpatient stroke unit. 
An opt-in approach was used to recruit participants on the stroke unit. Over 
the course of a 5 month period from December 2011 to May 2012 the author and 
colleagues from the Clinical Health Psychology Department attended weekly 
multidisciplinary meetings on the stroke unit to find out which patients may be 
suitable to complete the mood assessment measures. As part of care as usual, 
patients on the unit were being screened for depression and anxiety using the Yale 
Q2, the HADS, the Depression Intensity Scale Circles (DISCs) and the Stroke 
Aphasic and Depression Questionnaire (SADQ; see Appendix D). The BASDEC 
was also being used on the unit by a volunteer initiative. Potential participants were 
provided with an information sheet about the study. When requested, the author read 
through the information sheet with the participant and answered any questions about 
the study. If the participant was willing to take part, they were asked to sign a 
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The MoCA was always performed first in case there was any doubt about consent 
issues. The DT, HADS and BASDEC were then performed in a counterbalanced 
order. The Yale Q2 was completed by a member of the multidisciplinary team on 
admission to the unit. With the participant’s consent, copies of the measures were 
kept in their medical file and the results and any unmet needs were fed back to the 
participant and the team. 
 
Charity participants. 
An opt-in approach was used to recruit participants affiliated with charities 
such as Headway and The Stroke Association. The author contacted the organisers of 
ten charities and attended two Stroke Association meetings. Suitable stroke survivors 
were identified by charity organisers who had a preliminary conversation with them 
to see if they might like to take part in the study. Information packs containing an 
invitation letter, information sheet, consent form, and stamped addressed envelope 
were handed out by the charity organisers and during the Stroke Association 
meetings (Appendix L). Once the completed consent forms had been returned, the 
author made contact with the participant to arrange a convenient time and place 
(either at their home or at the stroke club) to meet and complete the questionnaires. 
Before completing the questionnaire, the author explained the purpose of the study 
again, emphasised the right to withdraw, and allowed time for any questions. As 
with the inpatient subgroup, the MoCA was completed first, and the Yale Q2, 
BASDEC, HADS and DT were completed in a counterbalanced order. At the end of 
the assessment the results were fed back to the participant and they were asked 
whether the questionnaires had raised any areas of concern or unmet need which 
may require signposting to other services.   
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Statistical Analysis 
 
The data was analysed using SPSS version 19, Microsoft Excel 2007 and 
MedCalc version 12. Due to a small sample size and all three mood assessment 
measures consisting of ordinal data, Spearman’s correlation coefficients were used to 
determine the association between measures (Field, 2009). Receiver-operating 
characteristic (ROC) curves were used to evaluate the ability of the DT, BASDEC 
and Yale to identify distressed cases as defined by cut-off scores on the HADS-D 
(≥4 and ≥8), HADS-A (≥4 and ≥8) and HADS-T (≥11). ROC curves are graphical 
representations which plot the sensitivity of an index test on the X axis and plot      
1-specificity on the Y axis relative to every possible cut-off score on the criterion 
standard. The primary statistic generated from a ROC curve is called the Area Under 
the Curve (AUC). The larger the AUC the more accurate the index test (Pintea & 
Moldovan, 2009). The AUC was calculated for all measures. An AUC of 1.0 
represents a perfect test and an AUC of 0.50 suggests that the index test performed 
no better than chance when discriminating between someone with or without the 
disorder (null hypothesis). Cohen’s Kappa was performed to measure the agreement 
between the number of people meeting the cut-off level for depression, anxiety, and 
general distress relative to the HADS, DT, BASDEC and Yale. Internal consistency 
coefficient alphas were calculated for the PL and each domain. 
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Sample size calculation 
 
A priori power analysis was undertaken using MedCalc version 12 to 
estimate the required sample size needed to produce an AUC for the DT
1 that was 
significant from the null hypothesis (AUC=0.50). Based upon research within 
cancer, which validated the DT against the HADS (Craike, Livingston, & Warne, 
2011; Goebel & Mehdorn, 2011), a total sample size between 36 and 70 cases was 
required, where the AUC was 0.77 and 0.87 (alpha level = .05, beta-level = .20). 
However, Metz (1978, p. 293) highlights that a minimum of 100 cases are needed to 
draw any “meaningful qualitative conclusions” from ROC curve analyses. From the 
outset of the study the author aimed to recruit 100 participants; however, a notably 
smaller sample was achieved (N=31). 
 
Ethical considerations 
 
The local Research and Development Service at the Hospital was consulted 
and confirmed that the proposed study should be classified as service evaluation and 
would not require review by NHS Research Ethics Committee (Appendix M). 
Approval was then obtained from the University Ethics Committee (Appendix N).  
   
                                                             
1 An AUC for the BASDEC and Yale could not be found in the literature  
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Results 
 
Participant Characteristics 
 
Of the 31 participants assessed, 21 (67.7%) were inpatients on a stroke unit 
and 10 were (32.3%) recruited from charities and living at home.  Seventeen (54.8%) 
participants were women and 14 (45.2%) were men.  The total sample was aged 
between 30 and 100 years, with a mean age of 69.16 years (interquartile range: 62 to 
81 years).  Just over a quarter (29%) of the total sample were under the age of 65 
years (National Audit Office, 2005). A Mann-Whitney U test indicated that the 
charity subgroup (M = 61.30 years) was significantly younger than the inpatient 
subgroup (M = 72.90 years), U = 46.5, z = -2.48, p < .05, r = -.45. Time since stroke 
ranged from 1 day to 12.8 years (M = 13.8 months, interquartile range: 5 days to 9.3 
months). As one would expect, the time since stroke was significantly greater for the 
charity subgroup (M = 3.5 years) compared to the inpatient subgroup (M = 8.62 
days), U = 210.0, z = 4.44, p = .001, r = .80.  
 
Just under three quarters (71.4%) of the inpatient subgroup met the standard 
criteria on the MoCA (≤26) for MCI (M = 21.86, range: 11 to 28 out of 30). 
However, only 40% of the charity subgroup scored less than 26 out of 30 (M = 
25.40, range: 20 to 28).  The mean score on the DT was 4.26 (SD: 2.48), which was 
slightly higher than a mean of 3.80 (SD: 2.97) reported by Turner et al. (2012). The 
mean score on the BASDEC was 4.10 (SD: 2.63).  
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In relation to question seven of the BASDEC, “I’ve seriously considered 
suicide”, one participant from the inpatient subgroup reported that they had been 
suicidal prior to their stroke, but reported no current suicidal thoughts or plans.  
 
According to the Yale Q2, 70% of the inpatient subgroup and 30% of the 
charity subgroup stated that they had not been sad or depressed since their stroke. 
None of the charity subgroup stated that they would like any further support at the 
end of the assessment. Please refer to Tables 2, 3 and 4 for a detailed summary of the 
clinical and demographic characteristics of the sample. 
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Table 1 
Clinical and Demographic Characteristics of the Total Sample and Inpatient and 
Charity Subgroups 
  N (%) 
Characteristic  Total (N=31)  Inpatients (n=21)  Charity (n=10) 
Age       
       65 years and over  22 (71.0)  18 (85.7)  4 (40.0) 
       Under 65 years  9 (29.0)  3 (14.3)  6 (60.0) 
Gender        
      Male  14 (45.2)  9 (42.9)  5 (50.0) 
      Female  17 (54.8)  12 (57.1)  5 (50.0) 
Ethnicity       
      White British  29 (93.5)  20 (95.2)  9 (90.0) 
      White Scottish  1 (3.2)  1 (4.8)   
       Black British 
Caribbean 
1 (3.2)    1 (10.0) 
Marital status       
      Married  17 (54.8)  9 (42.9)  8 (80.0) 
      Cohabiting  2 (6.5)  2 (9.5)   
      Divorced  1 (3.2)    1 (10.0) 
      Widowed  7 (22.6)  7 (33.3)   
      Single  4 (12.9)  3 (14.3)  1 (10.0) 
Have children  25 (80.6)  16 (76.2)  9 (90.0) 
Do not have children  6 (19.4)  5 (23.8)  1 (10.0) 
Occupational status       
      Employed  6 (19.4)  4 (19.0)  2 (20.0) 
      Unemployed  5 (16.1)  1 (4.8)  4 (40.0) 
      Retired  20 (64.5)  16 (76.2)  4 (40.0) 
First time stroke  26 (83.9%)  16 (76.2)  10 (100) 
Second stroke  5 (16.1%)  5 (23.8)   
CVA location       
      Right hemisphere  18 (58.1)  11 (52.4)  7 (70.0) 
       Left hemisphere  8 (25.8)  5 (23.8)  3 (30.0) 
       Bilateral  3 (9.7)  3 (14.3)   
       Unknown  2 (6.5)  2 (9.5)   
CVA type       
       Ischemic  18 (58.1)  13 (61.9)  5 (50.0) 
       Hemorrhagic  5 (16.1)  4 (19.0)  1 (10.0) 
       TIA  2 (6.5)  2 (9.5)   
       Unknown  6 (19.4)  2 (9.5)  4 (40.0) 
Yale Q1
        
       Yes  7
 a (23.3)
   6
 b (28.6)  1 (10.0) 
       No  23
 a (76.7)  14
 b (66.7)  9 (90.0) 
        Note. N = number of cases; CVA = cerebrovascular accident; TIA = transient 
ischemic attack.    
a due to missing data N=30        
b due to missing data n=20   
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Table 2 
Means, Standard Deviations and Mann Whitney U Test Results Relative to the 
Demographic Characteristics of the Sample and Self-Report Measures  
  M (SD)   
Characteristic  Total (N=31)  Inpatients (n=21)  Charity (n=10)  U  p 
           
Age (years)   69.16 (15.49)  72.90 (16.8)  61.30 (11.12)  46.5  .013* 
Time since 
stroke (days) 
419.29 
(993.92) 
8.62 (6.57)  1281.70 
(1439.77) 
210.
0 
.000*
* 
MOCA  23.00 (4.93)  21.86 (5.34)  25.40 (2.84)  147.
5 
.069 
DT  4.26 (2.48)  4.67 (2.42)  3.4 (2.50)  70.5  .142 
BASDEC  4.10 (2.63)  4.05 (2.92)  4.20 (2.03)  117.
5 
.102 
HADS-D  5.71 (3.98)  6.52 (4.36)  4.00 (2.40)  66.5  .882 
HADS-A  5.94 (3.50)  6.10 (3.62)  5.60 (3.41)  101.
5 
.270 
HADS-T  11.65 (6.48)  12.62 (7.03)  9.60 (4.84)  79.0  .595 
            Note. N= number; M= mean; SD = standard deviation; U = Mann Whitney U test; 
MOCA =Montreal Cognitive Assessment; DT = Distress Thermometer; BASDEC = 
Brief Assessment Schedule Depression Cards; HADS-D = Hospital Anxiety and 
Depression Scale – depression subscale; HADS-A = Hospital Anxiety and 
Depression Scale – anxiety subscale; HADS-T = = Hospital Anxiety and Depression 
Scale – total score. 
*p<.05, two tailed 
**p<.001 
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Prevalence of Clinically Significant Distress  
When using a cut-off score of at least 8 on the HADS-D and HADS-A, a 
third of the total sample (32.3%) scored within the clinical range for anxiety and 
depression. However, the majority of these cases were classified within the mild 
range of severity, with only two participants experiencing severe levels of 
depression. When using a lower cut-off score of at least 4 on the HADS, the total 
number of participants being classified within the clinical range for anxiety and 
depression doubled (Tables 4 and 5). 
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Table 3 
Number and Percent of Participants Classified within the Clinical Range for Mild 
Cognitive Impairment and Post-Stroke Distress  
  N (%) 
Measure  Total (N=31)  Inpatients (n=21)  Charity (n=10) 
        MOCA <26*  19 (61.3) 
3 
15 (71.4)  4 (40.0) 
MOCA <20  7 (22.6)  7 (33.2)  0 (0.0) 
HADS-D ≥8*  10 (32.3)  9 (42.9)  1 (10.0) 
HADS-D ≥4  21 (67.7)  16 (76.2)  5 (50.0) 
HADS-A ≥8*  10 (32.3)  6 (28.6)  4 (40.0) 
HADS-A ≥4  23 (74.2)  16 (76.2)  7 (70.0) 
HADS-T ≥11  18 (58.1)  13 (61.9)  5 (50.0) 
BASDEC ≥ 7*  6 (19.4)  5 (23.8)  1 (10.0) 
DT ≥4*  20 (64.5)  16 (76.2)  4 (40.0) 
DT ≥5*  16 (51.6)  14 (66.7)  2 (20.0) 
Yale Q2: Yes  13
 a (43.3)  6
 b (30.0)  7 (70.0) 
        Note. N = number of cases; HADS-D = Depression subscale of the Hospital Anxiety 
and Depression Scale; HADS-A = Anxiety subscale of the Hospital Anxiety and 
Depression Scale; HADS-T = Total score for the Hospital Anxiety and Depression 
Scale. 
*standard cut-off scores 
Cut-off scores recommended in the stroke literature 
a due to missing data N=30  
b due to missing data n=20 
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Table 4 
Interpretation of the HADS Scores  
    N (%) 
Criterion 
standard 
Interpretation   Total  
(N=31) 
Inpatients  
(n=21) 
Charity  
(n=10) 
         
HADS-D  Normal  21 (67.7)  12 (57.1)  9 (90.0) 
  Mild  8 (25.8)  7 (33.3)  1 (10.0) 
  Moderate       
  Severe  2 (6.5)  2 (9.5)   
         
HADS-A  Normal  21 (67.7)  15 (71.4)  6 (60.0) 
  Mild  7 (22.6)  4 (19.0)  3 (30.0) 
  Moderate   3 (9.7)  2 (9.5)  1 (10.0) 
  Severe       
Note. N = number of cases; HADS-D = Hospital Anxiety and Depression Scale – 
depression subscale; HADS-A = Hospital Anxiety and Depression Scale – anxiety 
subscale; ‘normal’ represents scores of 0-7; ‘mild’ represents scores of 8-10; 
‘moderate’ represents scores of 11-14; and ‘severe’ represents scores of 15-21. 
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Concurrent Validity of the DT, BASDEC and Yale Q2 
 
The DT was significantly correlated with all four measures, including the 
BASDEC (rs =  .55, p <.01; rs
2 = .30), HADS-D (rs =  .44, p <.05; rs
2 = .19), HADS-
A (rs =  .55, p <.01; rs
2 = .30) and HADS-T (rs =  .58, p <.01; rs
2 = .34), sharing 
between 19 and 34% of the variance in the ranks with each of the four measures. The 
BASDEC was not significantly related to the HADS-D, but was significantly related 
to the HADS-A (rs = .36, p <.05, rs
2 = .13), and HADS-T (rs = .37, p <.05, rs
2 = .14), 
sharing between 13 and 14% of the variance in the ranks with each measure. In terms 
of the criterion standards, the HADS-D and HADS-A were significantly related to 
one another (rs = .47, p <.01, rs
2 = .22), sharing 22% of the variance in ranks (Table 
6). In contrast, the Yale Q2 was not significantly associated with any of the 
measures, relative to the standard and stroke cut-off scores specified in Table 4 
(Fisher’s exact test, p >0.05).  
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Table 5 
Correlations between the DT, BASDEC, HADS-D, HADS-A and HADS-T 
Measure  1  2  3  4  5 
1. DT  -  .55**  .44*  .55**  .58** 
2. BASDEC    -  .22  .36*  .37* 
3. HADS-D      -  .47**  - 
4. HADS-A        -  - 
5. HADS-T          - 
Note. DT =Distress Thermometer; BASDEC = Brief Assessment Schedule 
Depression Cards; HADS-D = Depression subscale of the Hospital Anxiety and 
Depression Scale; HADS-A = Anxiety subscale of the Hospital Anxiety and 
Depression Scale; HADS-T = Total score for the Hospital Anxiety and Depression 
Scale. 
** p<.01, two tailed. 
* p <.05, two tailed. 
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Diagnostic Accuracy of the DT, BASDEC and Yale Q2 
 
ROC curve analyses were performed to evaluate the accuracy of the DT, 
BASDEC and Yale Q2 at detecting clinically significant levels of post-stroke 
distress relative to the HADS. As a general rule of thumb, an AUC between 0.50 and 
0.70 represents “low” accuracy; between 0.70 and 0.90 “moderate” accuracy; and 
over 0.90 “high” accuracy (Fischer, Bachmann, & Jaeschke, 2003, p. 1047). When 
inspecting the ROC curves, the further the curve lies above the reference line (in 
other words, the further the curve is to the left-hand corner of the graph), the more 
accurate the test is at identifying stroke survivors with or without clinically 
significant levels of distress (Figures 3-5). Ideal cut-off scores were determined 
when recommended levels of sensitivity (≥0.80) and specificity (≥0.60) were 
obtained (Bennett & Lincoln, 2006). Cut-off scores corresponding with the highest 
Youden Index (highest average of sensitivity and specificity) were also calculated 
(Table 7).  
 
Accuracy of the Distress Thermometer.  
 
Depression. 
The DT obtained an AUC of 0.74 relative to the HADS-D (≥8), which was 
significantly greater than an AUC of 0.50 (p<0.01). This suggested that the DT was 
able to distinguish between clinical and non clinical levels of depression better than 
chance.  An ideal cut-off score of at least 5 on the DT met recommended levels of 
sensitivity and specificity and also yielded the highest Youden Index (Table 7 and 
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A fair level of agreement between the DT (≥5) and HADS-D (≥8) at 
identifying clinical cases was found (k = 0.36, p <0.05; Table 8). Just under a third 
(32%) of the total sample scored at least 8 or more for depression.  When the DT 
obtained a positive result (a score of at least 5), there was a 50% probability (PPV = 
0.50) that this result was true and the person was experiencing clinical levels of 
depression. When a negative result was obtained on the DT, there was an 87% 
chance (NPV = 0.87) that the DT was correct and the person was not meeting 
clinical levels of depression.  
 
Anxiety.  
In relation to the HADS-A (≥8), the AUC for the DT of 0.68 was not 
significantly greater than an AUC of 0.50 (Appendix O). However, when using a 
lower cut-off score, the DT obtained an AUC of 0.86 relative to the HADS-A (≥4) 
and an AUC of 0.74 relative to the HADS-T (≥11), both of which were significantly 
greater than an AUC of 0.50 (p<0.05). An ideal cut-off score of at least 4 on the DT 
met recommended levels of accuracy when screening for anxiety and emotional 
distress (Table 7 and Figures 4 and 5).   
 
A good level of agreement between the DT (≥4) and the HADS-A (≥4) and 
HADS-T (≥11) at identifying clinical cases was found (k = 0.63 and 0.46 
respectively, p <0.05; Table 8). However, an AUC of 0.67 was not significantly 
greater than the null hypothesis for the HADS- D (≥4). Furthermore, due to lower 
cut-off scores on the HADS, the prevalence of participants meeting clinical levels of 
anxiety (74%) and emotional distress (58%) increased beyond published base rates 
(Sagen, et al., 2009; Turner, et al., 2012).   
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Consequently, the PPVs (0.95 and 0.75, respectively) and NPVs (0.64 and 0.73, 
respectively) should be viewed with caution (Baldessarini, Finklestein, & Arana, 
1983).    
 
Accuracy of the BASDEC and Yale Q2. 
 
In relation to the HADS-D and HADS-T, the AUCs for the BASDEC (0.68 
and 0.67) and Yale Q2 (0.53 and 0.67) were not significantly different to an AUC of 
0.50 (Appendix O). As illustrated in Table 8, the BASDEC and Yale Q2 did not 
show any significant agreement with the HADS-D and HADS-T but the BASDEC 
did show good agreement with the HADS-A (k = 0.63, p<0.01).  
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Table 6 
Validity of the DT where the AUC was Significantly Greater than the Null Hypothesis (AUC=0.50) and Sensitivity was at Least 0.80 and 
Specificity was at Least 0.60 
Reference  
standard 
 
 
Cut 
off 
Index test 
positive/  
HADS 
positive  
Index test 
negative/ 
HADS 
negative 
Sensitivity  
(95% CI) 
Specificity  
(95% CI) 
PPV  
(95% CI) 
NPV  
(95% CI) 
AUC  
(95% CI) 
SE 
HADS-D (≥8)  ≥5  16/10  15/21  0.80 (0.44-0.98)  0.62 (0.38-0.82)  0.50 (0.25-0.75)  0.87 (0.58-0.99)  0.74* (0.56-0.88)  0.09 
HADS-A (≥4)  ≥4  20/23  11/8  0.83 (0.61-0.95)  0.88 (0.47-1.0)  0.95 (0.75-1.0)  0.64 (0.31-0.89)  0.86** (0.69-0.96)  0.09 
HADS-T (≥11)  ≥4  20/18  11/13  0.83 (0.59-0.96)  0.62 (0.32-0.86)  0.75 (0.51-0.91)  0.73 (0.37-0.95)  0.74* (0.55-0.88)  0.10 
Note. HADS-D = Hospital Anxiety and Depression Scale – depression subscale; HADS-A = Hospital Anxiety and Depression Scale – anxiety 
subscale; HADS-T = Hospital Anxiety and Depression Scale – total score; PPV=Positive Predictive Value; NPV = Negative Predictive Value; 
CI = confidence interval; AUC = area under the curve; SE = Standard error. 
* p<0.01 
**p<0.001 
 Optimal cut-off score determined using the Youden Index 
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Figure 3. Receiver operating characteristic (ROC) curve evaluating the ability of the 
Distress Thermometer (DT) to detect possible cases of post-stroke depression using 
the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D ≥8) 
as the criterion standard. AUC = 0.74. 
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Figure 4. Receiver operating characteristic (ROC) curve evaluating the ability of the 
Distress Thermometer (DT) to detect possible cases of post-stroke anxiety using the 
anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A ≥4) as the 
criterion standard. AUC = 0.86. 
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Figure 5. Receiver operating characteristic (ROC) curve evaluating the ability of the 
Distress Thermometer (DT) to detect possible cases of post-stroke distress using the 
Hospital Anxiety and Depression Scale - total score (HADS-T ≥11) as the criterion 
standard. AUC = 0.74. 
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DT cut-off: ≥4 
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Table 7 
Cohen’s Kappa Measure of Inter-Rater Reliability  
Measure  DT ≥5  DT ≥4  BASDEC ≥7  Yale Q2 
HADS-D ≥8  0.36*  0.30*  0.18  0.08 
HADS-D ≥4  0.41*  0.21  0.10  0.02 
HADS-A ≥8  0.24  0.19  0.34*  0.00 
HADS-A ≥4  0.41*  0.63**  0.15  -0.08 
HADS-T ≥11  0.48**  0.46*  0.18  0.03 
Note. DT =Distress Thermometer; BASDEC = Brief Assessment Schedule 
Depression Cards; HADS-D = Depression subscale of the Hospital Anxiety and 
Depression Scale; HADS-A = Anxiety subscale of the Hospital Anxiety and 
Depression Scale; HADS-T = Total score for the Hospital Anxiety and Depression 
Scale 
*p<0.05 
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Problem List 
 
  The total score on the PL and physical domain demonstrated an acceptable 
level of internal consistency (Cronbach’s α = .84 and .71 respectively). In contrast, 
the internal consistencies of the practical (α = .38), family (α = .59), emotional (α = 
.69) and cognitive domains (α = .57) were poor. While the total number of problems 
reported did not significantly relate to the DT (rs= .27, p=.146), a significant 
correlation was found between the total number of problems reported within the 
emotional domain and DT (rs= .41, p <.05; Table 10).  
 
Fisher’s exact tests were used to determine whether cut-off scores of at least 
4 or at least 5 on the DT were associated with the selection of items on the PL. Of 
the 41 items, a score of at least 5 on the DT was significantly associated with the 
selection of fears (Fisher’s Exact test, p<0.05). In relation to the HADS-A (≥8), 
family health issues, fears, nervousness and confusion were significantly associated 
with scoring in the clinical range for anxiety.  In relation to the HADS-D (≥8), a 
further six item were significantly related to scoring in the clinical range for 
depression, these included concerns with hobbies and partner, loss of interest in 
usual activities, problems with sleep, swallowing and tingling in hands and feet.  
 
The frequency and percentage of all items identified as a problem or a 
concern are presented in Appendix P.  Overall, the mean number of items selected 
was 8.84 (range: 3 to 28 items). Two items were not selected by anyone: child care 
and ability to have children. The least frequently reported item was spiritual or 
religious concerns, with one person indentifying this as a problem.                           VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS      131 
 
 
 
In contrast, the most consistent and frequently ranked items across all population 
groups were movement, muscle weakness and fatigue. Over half the study population 
indicated that these items had been a problem for them in the past week. This 
suggested that problems or concerns with movement and fatigue were not only 
present within the acute and sub-acute phases of recovery but persisted many years 
after having had a stroke. Just under half (43%) of the inpatient subgroup reported 
difficulties around sleep and fears (Table 9).  
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Table 8 
Mean Number of Items Selected, Cronbach’s Alphas and the Most Frequently 
Reported Item within Each Domain of the PL Relative to the Total Sample 
Problem List 
Domain 
M (SD)  α  Highest item (%) 
        Practical  1.26 (1.26)  0.38  Driving (29) 
Family  0.52 (0.93)  0.59  Children (22.6) 
Family health issues (22.6) 
Emotional   2.06 (1.90)  0.69  Worry (41.9) 
Physical  4.19 (3.29)  0.80  Movement (61.3) 
Muscle weakness or paralysis (61.3) 
Cognitive  0.65 (0.88)  0.57  Memory (38.7) 
Spiritual
 a  0.03 (0.18)     
Total Problem List  8.84 (6.0)  0.84  Movement (61.3) 
Muscle weakness or paralysis (61.3) 
Note. M = mean; SD = standard deviation; α = Cronbach’s alpha. 
a spiritual domain consists of one item  
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Table 9 
Correlations between the DT, PL Total Score and Individual Domains 
Measure   1  2  3  4  5  6  7  8 
                  1. DT  -  .27  .14  .09  .41*  .20  .32  .31 
2.Total PL    -  .43*  .53**  .59**  .77**  .54**  .27 
3. Practical      -  .32  .15  .13  .19  .32 
4. Family        -  .19  .34  .45*  -.15 
5. Emotional          -  .21  .36*  .29 
6. Physical            -  .29  .02 
7. Cognitive              -  .15 
8. Spiritual                - 
Note. DT = Distress Thermometer; PL = Problem List 
*    p<0.05 
** p <0.01 
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Discussion 
 
The study investigated the accuracy of three self-report mood screening 
measures with a heterogeneous sample of stroke survivors. The performance of three 
index tests, the DT, BASDEC and Yale Q2, was compared against three criterion 
standards, the HADS-D, HADS-A and HADS-T. A primary aim of the study was to 
evaluate whether each index test met recommended levels of sensitivity (≥0.80) and 
specificity (≥0.60) for a screening tool within stroke (Bennett & Lincoln, 2006).  
 
Prevalence of Post-Stroke Distress 
 
When using a cut-off score of at least 8 on the HADS-D and HADS-A 
(Snaith & Zigmond, 1994) the overall prevalence rates for depression and anxiety 
(32.3%) were comparable to base rates reported within the stroke literature of around 
33% (De Wit, et al., 2008; Hackett, et al., 2005). However, the majority of clinical 
cases fell within the mild range of severity. Only two participants from the inpatient 
subgroup scored within the severe range for depression. The Stroke Quality 
Standards (NICE, 2010) specify that all patients should be screened for mood 
disturbance within 6 weeks of diagnosis. However, Gillham and Clark (2011, p. 11) 
argue that “screening in the first few days is likely to be an unreliable measure of 
mood”. Due to the provision of early supported discharge (Langhorne et al., 2005) 
nine participants had been screened within the first week of having a stroke, which 
may have resulted in lower levels of depression being reported. Furthermore, 
participants from the stroke unit may not have had time to develop awareness into 
the consequences of their stroke (Fure, Wyller, Engedal, & Thommessen, 2006).  136       VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS       
 
 
 
Only one stroke survivor from the charity subgroup scored within the clinical 
range for depression (mild range).  Stage models of adjustment suggest that the 
immediate period following discharge from hospital is one of the most challenging 
phases (Ch'Ng, et al., 2008; Wade, Langton Hewer, Skilbeck, & David, 1985). A 
limitation of this study was that it did not include people within the first few weeks 
of discharge. However, it was notable (albeit non-significant, Fisher’s exact test, 
p=0.056) that 70% of charity participants said that they had often felt sad or 
depressed following their stroke on the Yale Q2. Unlike the HADS or DT, the Yale 
Q2 is not limited to a specific time period. It can by hypothesised that a higher 
number of positive responses on the Yale Q2 (70%) in contrast to the HADS-D 
(10%) may have related to a process of adjustment. It is also possible that charity 
group members were less likely to consent to take part in the study if they were 
feeling depressed.   Consequently, the ability to generalise these findings to other 
clinical settings where the rates of depression are higher is limited. 
 
A higher proportion of charity participants reported clinical levels of anxiety 
(40%) compared to the inpatient population (28.6%). This supports the need to 
screen for anxiety disorders in addition to depression during all stages of the stroke 
care pathway (Intercollegiate Stroke Working Party, 2008). A focus of this study was 
to evaluate a mood assessment pathway being used on an acute stroke unit 
(Appendix D).  At present, all patients are screened with the Yale Q2 to determine 
whether they need to complete the HADS or DISCs. However, the Yale question 
was not designed to screen for anxiety.  Theoretically, this could result in a number 
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Consequently, an accurate yet brief and accessible screening measure for anxiety is 
needed to replace the Yale Q2 when used as the first point of contact within a mood 
assessment pathway.  
 
Concurrent Validity of the DT 
 
At the commencement of this study, the DT had not been validated among 
stroke survivors, despite being recommended by NICE (2009). However, due to a 
small sample size the ability to investigate an ideal cut-off score on the DT was 
purely exploratory and these results need to be replicated with a larger sample before 
being generalised to clinical practice.  
 
The DT significantly correlated with all measures. However, the correlations 
only accounted for 19 to 34% of the variance in ranks. When using the HADS-D 
(≥8) and HADS-T (≥11) as a criterion standard, the AUC (0.74 and 0.86 
respectively) fell within the moderate range of accuracy (Fischer, et al., 2003) and 
was significantly greater than an AUC of 0.50. These results provide preliminary 
evidence for the concurrent validity of the DT as a screening tool for symptoms of 
post-stroke depression and overall distress.  
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A cut-off score on the DT of at least 5 for depression and at least 4 for 
emotional distress met recommended levels of sensitivity and specificity (Bennett & 
Lincoln, 2006). While this is comparable to cut-off scores recommended within 
oncology (Baken & Woolley, 2011; Craike, et al., 2011; NCCN, 2011), this finding 
is not supported by  a recent study among stroke survivors where the sensitivity 
(0.69) and specificity (0.57) of the DT fell below recommended levels when using a 
cut-off score of at least 4 (Turner, et al., 2012). 
 
The AUC for the DT, relative to the HADS-A (≥8), was not significantly 
different to an AUC of 0.50. When lowering the cut-off score on the HADS-A to at 
least 4 (O'Rourke, et al., 1998) the AUC of 0.86 was significantly greater than an 
AUC of 0.50. Furthermore, a cut-off score of at least 4 met recommended levels of 
accuracy (Bennett & Lincoln, 2006). However, by lowering the cut-off score on the 
criterion standard, 64% of participants were classified as suffering from clinical 
levels of anxiety. This was higher than published base rates (Hackett & Anderson, 
2005) and would result in a higher proportion of patients requiring further 
assessment. Consequently, further research is needed to develop a brief screening 
tool for post-stroke anxiety, which meets recommended levels of accuracy. A single 
measure which can be used to screen for multiple domains of distress would appear 
to be preferable over two measures.  
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Concurrent Validity of the BASDEC and Yale Q2 
 
It seemed surprising that the BASDEC did not correlate significantly with the 
HADS-D, which was contrary to prior findings (Healey, et al., 2008). However, it is 
possible that a non-significant result was caused by a small sample size as opposed 
to the correlation not existing. A post hoc power analysis indicated that there was 
insufficient power (0.23) to detect the observed effect size (rs=.22; Appendix Q). 
However, the construct of the BASDEC differs to the HADS-D in two ways. First, 
the BASDEC includes questions about giving up hope and suicide whereas the 
HADS-D is based upon the construct of anhedonia (Zigmond & Snaith, 1983). 
Second, the BASDEC screens for depression prior to the person having a stroke 
whereas the HADS-D screens for depression within the last week. Both points may 
have contributed to a poor correlation and a non-significant AUC (Appendix O).  
 
A similar results was found for the Yale Q2, which was in contrast to prior 
findings (Turner-Stokes, Kalmus, Hirani, & Clegg, 2005; Watkins, et al., 2007). As 
with the BASDEC, this may have related to a number of methodological problems. 
All of the patients entering the stroke unit were being screened by the Yale Q2 on 
admission. Consequently, the time period between completing the Yale Q2 and the 
HADS, DT and BASDEC ranged from 0 to 22 days (M = 6 days). As a state 
condition, distress is likely to change over time (Chaplin, John, & Goldberg, 1988). 
It is possible that the Yale Q2 was not significantly associated with the other 
measures due to a time difference between administration. This finding highlights 
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Gillham and Clark (2011) suggest that mood assessment should take place on at least 
three occasions (just before discharge, 3 months and 6 months post stroke). To the 
author’s knowledge, the ability of the DT to detect change over time has not been 
investigated among stroke survivors.  
 
In summary, non-significant results may suggest that the BASDEC and Yale 
Q2 performed no better than chance. However, a major limitation of this study was 
its small sample size (N=31). Future research would need to replicate this study 
using a larger sample. MedCalc version 12 was used to carry out a priori power 
analysis. In order to correctly reject the null hypothesis (AUC = 0.50) when the AUC 
was 0.67 and 0.68, a sample size of at least 178 and 158 cases would be needed. 
Consequently, caution should be taken when generalising these findings.  
 
 
The Problem List 
 
The total number of problems selected on the PL did not significantly 
correlate with the DT (rs= .27, p=.146). This is in contrast to studies within oncology 
and among older adults (Bevans et al., 2011; Dilworth, Thomas, Sawkins, & 
Oyebode, 2011; Goebel & Mehdorn, 2011). 
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All participants reported at least three problems. However, nobody reported 
concerns about ability to have children or child care, which seems understandable 
when considering that the majority of participants were over the age of 65 years 
(71%). The two participants who reported concerns about work were both under the 
age of 65 years. Similarly, the majority of participants who reported concerns about 
money were younger stroke survivors (80%). While the older adult population are 
more likely to experience a stroke (National Audit Office, 2005), working age stroke 
survivors are more likely to live for longer and may have different needs (Lincoln, et 
al., 2012). Employment issues are often neglected following stroke, yet represent a 
significant concern for younger stroke survivors and have been linked to low self-
esteem (Corr & Wilmer, 2003).  
 
The most frequently selected items on the PL were movement and muscle 
weakness (61%). While the effects of a stroke are multifaceted, hemiparesis has been 
described as the “hallmark” of stroke (Intercollegiate Stroke Working Party, 2008, p. 
80). However, by running a Fisher’s exact test, the selection of movement and muscle 
weakness was not significantly associated with scoring within the clinical or non-
clinical range for anxiety or depression.  It is possible that the instructions for the PL, 
“please indicate if any of the following have been a problem for you in the past week 
including today”, resulted in people selecting items that were not necessarily related 
to the experience of distress. For example, three participants scored 0 on the DT and 
selected 4, 5, and 8 items on the PL.  
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 In contrast, the selection of fears was significantly associated with a score of 
at least 5 on the DT and a score of at least 8 on the HADS-A and HADS-D. 
Participants reported fears about the amount of recovery they would make, fears 
about having another stroke and fears about falling, which have all been documented 
within the stroke literature (Townend, Tinson, Kwan, & Sharpe, 2006; Watanabe, 
2005). The selection of nervousness was also significantly related to scoring within 
the clinical range for anxiety, which provides some evidence for the construct 
validity of the PL as a measure of generalised anxiety. However, it is notable that 
despite 29% of participants selecting depression on the PL, this item did not 
significantly relate to the HADS-D or DT. This may in part reflect the finding that 
the majority of participants who scored 8 or more on the HADS-D scored within the 
mild range.  
 
It must be noted that a significant association between clinical levels of 
distress and the selection of a specific item on the PL does not imply a causal 
relationship. In line with the ICF biopsychosocial model of functioning, health and 
disability (WHO, 2001) a bidirectional relationship may exist. While the selection of 
family health concerns, sleep and confusion were significantly associated with 
clinical levels of depression (HADS-D), research suggests that the mental health of 
carers (Klinedinst, et al., 2009), sleep related difficulties (W.-K. Tang et al., 2011) 
and cognitive impairment (Taylor, et al., 2011) not only contribute to the 
development of post-stroke depression but also result from it. Nonetheless, the 
results of this study provide preliminary evidence to support the use of a PL to assist 
staff and patients in identifying potential areas of distress and unmet needs.  
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Strengths, Limitations and Future Directions 
 
According to Whiting et al. (2004), the quality of a validation study can be 
considered in terms of its internal and external validity. Internal validity refers to the 
study design and conduct and external validity refers to the degree to which the 
results of a study can be applied to clinical practice.  
 
External validity.  
 
It is important to validate an index test with a sample that represents the 
clinical population (Whiting, et al., 2004). A strength of this study was the inclusion 
of stroke survivors under the age of 65 years. The proportion of younger stroke 
survivors (29%) represented published rates in the stroke literature (National Audit 
Office, 2005). However, these results would need to be replicated in settings where a 
higher proportion of patients are under the age of 65 years, in order to gain a better 
understanding and representation of the needs of younger stroke survivors.  
 
A limitation of this study, as with all of the validation studies identified in the 
literature review, is the exclusion of participants with moderate to severe cognitive 
and communication difficulties. This not only hinders the ability to generalise the 
current findings to all stroke survivors, but denies those with cognitive and 
communication difficulties the right to benefit from healthcare advances.  
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In hindsight, a less stringent exclusion criterion could have been used to 
enhance the current sample size. However, informed consent it a fundamental 
principle of clinical research and issues around capacity are raised when recruiting 
stroke survivors with moderate to severe cognitive and/or communication difficulties 
(BPS, 2010). While it is important to carry out research with people who lack 
capacity, ethical approval and provisions surrounding proxy consent are needed (The 
Stationery Office, 2007). As a result, future studies which investigate the validity of 
self-report mood screening measures with stroke survivors who have cognitive and 
communication difficulties are clearly needed. In doing so, consideration needs to be 
given to the assessment of capacity to consent to identify participants who lack 
capacity and the provision of proxy consent if the study is deemed to be in the 
person’s best interest.  
 
There is no reason not to screen for mood disorders in aphasic patients, 
particularly when the evidence points to an elevated risk of depression among people 
with communication difficulties (Astrom, Adolfsson, & Asplund, 1993; Laska, 
Mårtensson, Kahan, von Arbin, & Murray, 2007). It is possible that the DT and PL 
would be more accessible to people with communication difficulties compared to 
other measures, as it consists of a visual analogue scale and simple yes/no format.  
During the completion of this study, an aphasia-friendly version of the DT and PL 
was published (Lincoln, et al., 2012; Williams, Lowdon, & Thomas, 2010).  
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Internal validity.  
 
Due to a small sample size, there was an increased risk of making a Type II 
error, where non-significant results are falsely accepted. Although priori power 
analysis was undertaken, a number of methodological and clinical factors 
contributed to a limited sample size. These included the exclusion of participants 
unable to give informed consent due to comorbid dementia or moderate to severe 
cognitive and communication difficulties, patients being admitted to the stroke unit 
who did not have a stroke, and patients not being medically well. Such factors need 
to be considered when evaluating the clinical utility of a screening measure and 
highlight the importance of developing ultra-short yet accurate screening measures.   
 
Another limitation of the study was that participants were recruited via 
opportunity sampling. The accuracy of all four measures may be biased as the full 
spectrum of post-stroke distress was not measured. Due to an opt-in approach and 
exclusion criteria, it is possible that participants who were depressed and suffering 
from anxiety did not consent to take part in the study. The prevalence and severity of 
a condition is known to affect measurements of accuracy (Whiting, et al., 2004). 
While positive and negative predicative values are directly affected by prevalence 
rates, sensitivity and specificity rates are also affected by the spectrum of a condition 
(Whiting, et al., 2004). In settings where there is a greater proportion of people with 
clinically significant levels of distress, sensitivity rates are likely to be higher 
(Sackett & Haynes, 2002). It would have been interesting to investigate the accuracy 
of the DT, BASDEC and YQ2 with each subgroup of stroke survivors. However, 
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Lastly, the accuracy of the DT, BASDEC and Yale Q2 in this study was 
based upon the premise that the HADS was 100% sensitive and specific. As with 
most criterion standards, this is not the case. Consequently, positive and negative 
results on the DT, BASDEC and Yale Q2 may have been misclassified by the HADS 
(Whiting, et al., 2004).   
 
Clinical Implications  
 
The main purpose of validating a new measure is the hope that people being 
screened have a better health outcome compared to those who are not screened 
(Sackett & Haynes, 2002). While guidelines promote the screening of mood 
disturbance, they do not specify how someone should be supported thereafter 
(Intercollegiate Stroke Working Party, 2008; NICE, 2010) . This study aimed to 
evaluate the accuracy of the DT in view of using it within a mood assessment 
pathway, which would direct referrals and associated input. While the detection of 
clinically significant mood disorders is important, health care services are moving 
away from a medical-model which views health as the absence of disease, to a 
biopsychosocial model which views health along a continuum (WHO, 2001).  
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The modernisation of the NHS has promoted partnership working with 
patients and carers, as “experts in their own conditions” (DOH, 2004; Hilari, 
Wiggins, Roy, Byng, & Smith, 2003, p. 366). The DT and accompanying PL aim to 
promote a holistic and subjective assessment of someone’s needs.  While, the 
majority of stroke survivors may not meet clinical levels of anxiety or depression, 
many do experience less intense and persistent states of distress which warrant 
further support.  
 
As a one item self-report measure, the DT is a quick and easy self-report 
screening tool to use within inpatient and community settings. However, compared 
to longer self-report measures which assess multiple aspects of anxiety and 
depression, such as the HADS, the DT is unlikely to capture the same richness of 
information without further inquiry into the nature of someone’s distress. 
Consequently, the strength of the DT would appear to be the accompanying PL. In 
contrast to other self-report measures, the DT and PL have been developed as a 
semi-structured interview which aims to encourage a dialogue between staff and 
patients to highlight any unmeet needs and associated distress, whether these are 
within a clinically significant range or not. Furthermore, within oncology the DT and 
PL are also being used with members of the patient’s family (Bevans, et al., 2011). 
Due to the known bidirectional relationship between carer and patient wellbeing 
within stroke (Suh et al., 2005), future research is needed which evaluates the 
validity and clinical utility of the DT and PL among carers of stroke survivors.  
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Conclusions 
 
This study provides preliminary evidence in favour of using the DT and 
accompanying PL within stroke services. A cut-off score of at least 5 and at least 4 
met recommended levels of sensitivity and specificity when screening for depression 
and general distress (Bennett & Lincoln, 2006). However, the accuracy of the DT 
when detecting anxiety was less supportive, albeit significantly better than chance 
relative to a cut-off score of at least 4 on the HADS-A. Furthermore, the BASEDEC 
and Yale Q2 were not significantly accurate in screening for post-stroke depression. 
However, due to a number of methodological limitations, caution should be taken 
when generalising these findings. While national guidelines highlight the importance 
of screening for mood disturbances following stroke, they do not specify which 
measure to use (Intercollegiate Stroke Working Party, 2008). Local service providers 
are required to establish protocols which support patient well being (Gillham & 
Clark, 2011). The DT and PL have the potential to promote a holistic and person-
centred approach when detecting and managing of post-stroke distress.  
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Appendix A 
Search strategy used to identify studies meeting criteria for the literature review  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step 1: Searched for ‘stroke OR cerebrovascular accident’ 
AMED and Embase retrieved 234752 articles. CINAHL retrieved 45236 articles. 
MEDLINE retrieved 154241. PsycINFO retrieved 19422 articles 
 
Step 2: Searched for ‘distress OR mood OR anxiety OR depression’ 
AMED and Embase retrieved 11295 articles. CINAHL retrieved 2119 articles. 
MEDLINE retrieved 5563 articles. PsycINFO retrieved 2349 articles 
 
  Step 3: Searched for ‘screen OR assessment OR measure OR scale OR tool OR 
questionnaire OR instrument’ 
AMED and Embase retrieved 4376 articles. CINAHL retrieved 1220 articles. 
MEDLINE retrieved 1892 articles. PsycINFO retrieved 1115 articles 
 
 
 
Step 4: Searched for ‘sensitivity OR specificity’ 
AMED and Embase retrieved 201 articles. CINAHL retrieved 78 articles. MEDLINE 
retrieved 112 articles. PsycINFO retrieved 59 articles 
 
Step 7: Duplicate 
articles discarded 
Total articles: 24 
Step 5: Abstracts and/or full text were read. Articles were excluded if: 
  Participants had not had a stroke and/or were under the age of 18 years 
  The study was investigating the prevalence, predictor or treatment of post-
stroke distress 
  The assessment tool had been designed to measure quality of life 
  The study did not investigate criterion-related validity or provide measures of 
sensitivity and specificity 
  The paper contained no primary data (e.g. reviews/meta analysis) 
  The measure being investigated was an observer- or clinician-rated scale  
  The study investigated the ability of a measure to assess change over time 
  The study was not published in English 
 
Step 8: Cross 
referencing and 
hand searching: 
2 articles 
identified 
Step 6: Relevant articles 
retrieved: AMED and Embase: 
24 articles, CINAHL: 14 
articles, MEDLINE: 22 articles, 
PsycINFO: 15 articles 
 
 
26 
articles  
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Appendix B 
 
Psychometric Properties of Each Validation Study 
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        BAI  Schramke et al. (1998)  N=44  
 
M: 64.6  
      63.4 
GAD & other anxiety 
SCID-R 
2.4m-
7.02yrs 
≥16*  good  poor  -  -  - 
BDI  House et al. (1989)  n=95 (1m) 
n=122 (6m) 
n=115 (12m) 
18-96 
M:71.2 
MD, MIND & AD 
PSE: DSM-III 
1m 
 
 
6ms 
 
 
12ms 
≥5‡ 
≥10* 
 
≥5 
≥10* 
 
≥5 
≥10* 
1.0 
0.85 
 
1.0 
0.83 
 
0.90 
0.70 
0.59 
0.21 
 
0.54 
0.22 
 
0.50 
0.09 
- 
- 
 
- 
- 
 
- 
- 
- 
- 
 
- 
- 
 
- 
- 
- 
- 
 
- 
- 
 
- 
- 
BDI  Aben et al. (2002) 
 
N=202  
 
M: 68.5  SCID: MD 
SCID: MD & MIND 
1m  ≥10*‡ 
≥10* 
0.80 
0.77 
0.61 
0.65 
0.22 
0.38 
0.96 
0.91 
0.78 
0.79 
                Table B1 continues  
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Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        BDI  Berg et al. (2009) 
 
N=100  
 
≤70 
(M:55.2) 
DSM-III-R: MD 
 
 
 
2 wks 
2 ms 
6 ms 
12 ms 
18 ms 
≥10*‡ 
≥10*‡ 
≥7‡ 
≥10*‡ 
≥10*‡ 
 
0.80 
1.00 
1.00 
1.0 
0.83 
0.76 
0.76 
0.66 
0.86 
0.84 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0.88 
0.86 
0.88 
0.93 
0.89 
BDI-II  Lincoln et al. (2003)  N=143 
 
(M:66) 
 
SCAN: DSM-III-R 
 
 
SCAN: ICD-10  
MD & MIND 
1-6ms  ≥10* 
≥16 
 
≥10* 
≥13 
0.95 
0.91 
 
0.93 
0.83 
 
0.18 
0.56 
 
0.24 
0.44 
 
- 
- 
 
- 
- 
- 
- 
 
- 
- 
- 
- 
 
- 
- 
BDI-II  Turner-Stokes et al. (2005) 
 
N=114  
n=76 stroke 
(M:42.8)  DSM-IV: MD & MIND 
 
12wks  ≥14*  0.74  0.80  0.69  0.84  - 
BDI-II  Turner et al. (2012)  N=72  25-91 
(M:66.7) 
SCID: MD 
 
3wks-
45yrs 
≥14*‡ 
≥12‡ 
0.85 
0.92 
0.75 
0.71 
- 
- 
- 
- 
0.89 
                  Table B1 continues 
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Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        BDI-FS  Healey et al. (2008) 
 
N=49 
Inpatients 
 
65yrs+ 
(M:78.8) 
SCID: MD 
SCID: MD & MIND 
 
16-
113days  
≥4*  
≥4* 
0.71 
0.62 
0.74 
0.78 
0.31 
0.50 
0.94 
0.85 
- 
BASDEC  Healey et al. (2008)  N=49 
 
65yrs+ 
(M:78.8) 
SCID: MD 
SCID: MD & MIND 
 
16-
113days 
≥7*‡ 
≥7* 
1.00 
0.69 
0.95 
0.97 
0.78 
0.90 
1.00 
0.90 
- 
CES-D  Shinar et al. (1986)  N=27 
 
28-73 
(M:56) 
PSE: DSM-III  
MD & MIND  
 
7days -
6ms 
≥16*  0.73  1.0  1.0  0.84  - 
CES-D  Parikh et al. (1988)  N=80 
 
58.4 
(13.5) 
MD & MIND 
PSE: DSM-III 
1wk-2yrs  ≥16*‡ 
≥21 
0.86 
0.72 
0.90 
0.94 
0.80 
0.85 
- 
- 
- 
CES-D  Agrell and Dehlin (1989)  N=39     61-93 
(M:80) 
MD & MIND 
Psychiatric interview 
4m-
2.5yrs 
≥20  0.56  0.91  0.82  0.75  - 
CES-D  Rybarczyk et al. (1996)  N=50  
 
(M:71)  MD & MIND 
SADS-C: DSM-III  
23days 
±20 
≥21 
≥26‡ 
0.56 
0.82 
0.65 
0.65 
0.44 
0.65 
0.60 
0.76 
- 
                  Table B1 continues 
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Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        CES-D  Schramke et al. (1998)  N=44 
 
55.5-71.3  SCID-R: MD, MIND & 
DD 
 
0.2- 
7.02yrs 
≥16*  good  poor  -  -  - 
CES-D  Roger and Johnson-Greene (2009)  N=67   45-89 
(M:71) 
SCID: MD & MIND 
 
 
8days 
±4.5 
≥15 
≥16* 
0.66 
0.60 
0.68 
0.76 
0.34 
0.28 
0.35 
0.38 
0.71 
DISCs  Turner-Stokes et al. (2005)  N=114  
n=76 stroke 
 
(M:42.8)  MD & MIND 
Psychiatric interview: 
DSM-IV  
12wks  ≥2*  0.60  0.87  0.75  0.77  - 
DT  Turner et al. (2012)  N=72  25-91 
(M:66.7) 
SCID: MD 
 
3wks-
45yrs 
≥2 
≥4* 
1.0 
0.69 
0.33 
0.57 
- 
- 
- 
- 
0.73 
GHQ-30  O’Rourke et al. (1998)  N=105 
 
18-90 
(M:68) 
Any psychiatric disorder  
SADS:DSM-IV 
 
6m  ≥5* 
≥9‡ 
 
0.90 
0.80 
0.47 
0.76 
- 
- 
- 
- 
- 
                  Table B1 continues 
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Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        GHQ-28  Johnson et al. (1995)  N=66   23-95 
(M:71) 
MD & MIND 
 
 
GAD & Agoraphobia 
PAS – DSM-III 
4m  ≥5*‡ 
≥6 
 
≥5* 
0.89 
0.78 
 
0.71 
0.75 
0.81 
 
0.56 
0.47 
0.50 
 
0.30 
 
0.96 
0.94 
 
0.88 
- 
GHQ-28  Lincoln et al. (2003)  N=143   (M:66)  SCAN: DSM-III-R 
 
 
SCAN: ICD-10   
MD & MIND 
1-6ms  ≥5* 
≥8‡  
 
≥5* 
≥12‡ 
1.00 
0.85 
 
0.98 
0.81 
0.24 
0.61 
 
0.35 
0.68 
- 
- 
 
- 
- 
- 
- 
 
- 
- 
- 
GDS-30  Agrell and Dehlin (1989)  N=40    61-93 
(M:80) 
MD & MIND 
Psychiatric interview 
4m-
2.5yrs 
≥10‡  0.88  0.64  0.58  0.88  - 
GDS-30  Johnson et al. (1995)  N=66   
 
23-95 
(M:71) 
MD & MIND 
GAD & Agoraphobia 
PAS – DSM-III 
4m  ≥11*‡  
≥15  
0.84 
0.65 
0.66 
0.79 
0.53 
0.51 
0.90 
0.86 
- 
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Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        GDS-30  Sivrioglu et al. (2009)  N=85  25-87 
(M:60.1) 
DSM-IV: MIND 
Psychiatric interview  
17 days – 
2 yrs 
≥11* 
≥12 
≥9‡ 
≥8‡ 
0.69 
0.66 
0.80 
0.80 
0.75 
0.79 
0.61 
0.61 
0.67 
0.70 
0.60 
0.60 
0.77 
0.76 
0.81 
0.60 
0.82 
GDS-15  Tang et al. (2004a)  N=127  ≥65yrs 
(M:75.7) 
SCID: MD, MIND, DD  3ms  ≥7‡  0.89  0.73  0.37  0.98  0.90 
GDS-15  Tang et al. (2004b)  N=60  40-90 
(M:71.3) 
SCID-R:MD, DD & AD 
 
≤1m  ≥6  0.64  0.83  0.53  0.88  0.76 
GDS-15  Roger & Johnson-Greene (2009)  N=67  
 
45-89yrs 
(M:71) 
SCID: MD & MIND  8days 
±4.5 
≥3 
≥5* 
0.67 
0.46 
0.73 
0.90 
0.31 
0.23 
0.32 
0.49 
0.73 
GDS-15  Lee et al. (2008)  N=253 
 
50yrs+  DSM-IV: MD & MIND  
 
1m  ≥5*‡  0.84  0.77  0.75  0.85  - 
HADS-D 
HADS-A 
Johnson et al. (1995)  N=66   
 
23-95 
(m:71) 
MD & MIND 
GAD & Agoraphobia: 
PAS:DSM-III 
4m  ≥5 
≥6 
0.83 
0.80 
 
0.44 
0.46 
0.26 
0.31 
0.92 
0.89 
- 
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Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        HADS-D 
HADS-A 
O’Rourke et al. (1998)  N=105   18-90 
(M:68) 
MD, AD, DD 
Anxiety disorder
 a 
SADS: DSM-IV 
6m  ≥7‡ 
≥7‡ 
 
0.80 
0.83 
0.79 
0.68 
- 
- 
- 
- 
- 
HADS-D 
 
 
HADS-A 
 
 
HADS-T 
Aben et al. (2002)  
 
N=202  
 
56.9-80.1  SCID: MD 
SCID: MD&MIND 
 
SCID: MD 
SCID: MD&MIND 
 
SCID: MD 
SCID: MD&MIND 
 
1m+  ≥8* 
≥7 
 
≥5 
≥5‡ 
 
≥11‡ 
≥11‡ 
0.73 
0.73 
 
0.92 
0.89 
 
0.92 
0.87 
0.82 
0.79 
 
0.56 
0.72 
 
0.65 
0.70 
0.41 
0.51 
 
0.26 
0.64 
 
0.30 
0.45 
0.95 
0.91 
 
0.98 
0.92 
 
0.98 
0.95 
0.82 
0.83 
 
0.78 
0.77 
 
0.83 
0.84 
 
HADS-D  Tang et al. (2004c)  N=100  
 
60-94 
(M:74.2) 
SCID-R: MD, DD, AD 
 
3-4wks  ≥7 
≥8* 
0.88 
0.82 
0.55 
0.58 
0.28 
0.29 
0.96 
0.95 
- 
HADS-D  Tang et al. (2004a)  N=60  40-90 
(M:71.3) 
MD, DD, AD 
SCID: DSM-III-R 
≤1m  ≥4‡  0.86  0.78  0.55  0.93  0.84 
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Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        HADS-D  Healey et al. (2008)  N=49 
 
 
65yrs+ 
(M:78.8) 
SCID:MD 
SCID: MD & MIND 
  
16-113 
days  
≥8*‡ 
≥8* 
0.86 
0.62 
0.69 
0.69 
0.32 
0.42 
0.97 
0.83 
- 
HADS-D 
 
 
HADS-A 
 
 
HADS-T 
Sagen et al. (2009)  N=101  (M:54.5)  SCID: MD, MIND, DD 
 
 
SCID: anxiety disorder
 b 
 
 
SCID: MD, MIND, DD 
SCID: anxiety disorder
 b 
4ms  ≥4‡ 
≥8* 
 
≥4‡ 
≥8* 
 
≥11‡ 
≥6‡ 
0.84 
0.58 
 
0.83 
0.52 
 
0.90 
0.83 
0.73 
0.94 
 
0.65 
0.90 
 
0.83 
0.60 
0.42 
0.69 
 
0.41 
0.60 
 
0.55 
0.38 
0.95 
0.91 
 
0.93 
0.86 
 
0.97 
0.92 
0.87 
 
 
0.85 
 
 
0.91 
0.82 
HADS-D 
 
 
HADS-T 
Turner et al. (2012)  N=72  25-91 
(M:66.7) 
SCID: MD 
 
3wks-
45yrs 
≥6‡ 
≥8*‡ 
 
≥11‡ 
≥15‡ 
0.92 
0.92 
 
0.92 
0.85 
0.68 
0.63 
 
0.63 
0.75 
- 
- 
 
- 
- 
- 
- 
 
- 
- 
0.87 
 
 
0.85 
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Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        K-10  Turner et al. (2012)  N=72  25-91 
(M:66.7) 
SCID: MD 
 
3wks-
45yrs 
≥18 
≥20* 
≥26 
0.85 
0.77 
0.54 
0.59 
0.69 
0.95 
- 
- 
- 
- 
- 
- 
0.80 
PHQ-9  Williams et al. (2005)  N=316  -  SCID: MD 
SCID: Any depression 
 
1-2ms  ≥10*‡ 
≥10* 
0.91 
0.78 
0.89 
0.96 
- 
- 
- 
- 
0.96 
PHQ-9  de Man-van Ginkel et al. (2011)  N=171  20-97 
(M:70.6) 
CIDI: DSM-IV & ICD-
10 depression 
5-9wks  ≥10*‡  0.80  0.78  0.34  0.97  0.87 
PHQ-9  Turner et al. (2012)  N=72  25-91 
(M:66.7) 
SCID: MD 
 
3wks-
45yrs 
≥7‡ 
≥9 
≥10* 
0.85 
0.77 
0.69 
0.63 
0.75 
0.78 
- 
- 
- 
- 
- 
- 
0.82 
PHQ-2  Williams, et al. (2005)  N=316   -  SCID: MD 
SCID: Any depression 
1-2ms  ≥3‡ 
≥3 
0.83 
0.78 
0.84 
0.95 
- 
- 
- 
- 
- 
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Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        PHQ-2  de man-van Ginkel et al. (2011)  N=171  20-97 
(M:70.6) 
CIDI: DSM-IV & ICD-
10 depression 
5-9wks  ≥2  0.75  0.76  0.30  0.96  0.82 
PHQ-2  Turner et al. (2012)  N=72  25-91 
(M:66.7) 
SCID: MD 
 
3wks-
45yrs 
≥2 
≥3 
≥4 
0.77 
0.69 
0.62 
0.63 
0.83 
0.92 
- 
- 
- 
- 
- 
- 
0.83 
Smiley   Lee et al. (2008)  N=253 
 
50yrs+  Sad face 
Flat face 
Happy face 
DSM-IV: MD & MIND 
1m  Yes / 
No 
0.76 
0.98 
0.48 
0.77 
0.18 
0.73 
0.74 
0.50 
0.60 
0.79 
0.93 
0.66 
- 
SIDI  Rybarczyk et al. (1996)  N=50   (71±6.1)  MD & MIND 
SADS-C: DSM-III 
23 days 
±20  
≥17‡*  0.94  0.71  0.86  -  - 
SIDI  Roger & Johnson-Greene (2009)  N=67  
 
45-89yrs 
(M:71) 
SCID: MD & MIND 
 
 
8days 
±4.5 
≥10 
≥17* 
0.66 
0.19 
0.72 
0.95 
0.32 
0.10 
0.37 
0.46 
0.79 
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Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        SCL-90  Aben et al. (2002) 
 
N=202   56.9-80.1  SCID: MD 
SCID: MD & MIND 
 
1m+  ≥25‡ 
≥25‡  
 
0.89 
0.88 
0.61 
0.66 
0.28 
0.44 
0.97 
0.95 
0.81 
0.85 
VAMS  Bennett et al. (2006)  N=100 
 
65-76 
(M:71.5) 
HADS-D 
HADS-A 
2-4wks  ≥124 
≥256 
0.81 
0.71 
0.51 
0.66 
- 
- 
- 
- 
- 
- 
VAMS-
SAD 
Bennett et al.(2006)  N=100  65-76 
(M:71.5) 
HADS-D 
 
2-4wks  ≥23‡  0.88  0.62  -  -  - 
VAMS-
SAD 
Berg et al. (2009)  N=100  
Inpatients & 
outpatients 
≤70 
(M:55.2) 
 
MD 
Psychiatric Interview: 
DSM-III-R 
2 ms 
6 ms 
12 ms 
18 ms 
≥50 
≥50 
≥50 
≥50 
0.20 
0.40 
0.00 
0.60 
0.84 
0.89 
0.93 
0.87 
- 
- 
- 
- 
- 
- 
- 
- 
ns 
ns 
ns 
0.85 
VASES  Bennett et al. (2006)  N=100 
 
65-76 
(M:71.5) 
HADS-D 
HADS-A 
2-4wks  ≥32 
≥34 
0.81 
0.73 
0.05 
0.15 
- 
- 
- 
- 
- 
- 
WDI  Lincoln et al. (2003)  N=143   (M:66)  SCAN: ICD-10   
SCAN: DSM-III-R 
1-6ms  ≥19 
≥21 
0.92 
0.86 
0.46 
0.50 
- 
- 
- 
- 
- 
- 
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Note. Time = time since stroke; Sens. = sensitivity; spec. = specificity; PPV = positive predictive value; NPV = negative predictive value; M= Mean; GAD = 
generalized anxiety disorder; MD = major depression; MIND = minor depression; AD = adjustment disorder; DD: Dysthmic Disorder; CIDI = Composite 
International Diagnostic Interview; DSM-IV= Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; DSM-III-R = Diagnostic and Statistical 
Manual of Mental Disorders, Third Edition, Revised; ICD-10 = International Statistical Classification of Diseases and Related Health Problems 10
th Revision; 
SCID-R = Structured Clinical Interview for DSM-III-R; SCID =  Structured Clinical Interview for DSM-IV; SCAN = Schedules for Clinical Assessment in 
Neuropsychiatry; PSE = Present State Examination; SADS-C = Schedule for Affective Disorders and Schizophrenia – Change version; MADRS = 
Montgomery–Åsberg Depression Rating Scale 
Table B1 continued                     
Measure  Study  Sample  Age (yrs)  Criterion standard  Time  Cutoff  Sens.  Spec.  PPV  NPV  AUC 
                        Yale  Watkins et al. (2001)  N=79 
 
70-79 
(M:75) 
MADRS  7-14days  Yes/ 
No‡ 
0.86  0.78  0.82  0.82  - 
Yale  Turner-Stokes et al. (2005)  N=114 
n=76 stroke 
 
(M:42.8)  MD & MIND 
Psychiatric interview: 
DSM-IV  
 
(12wks)  Yes/ 
No 
0.68  0.73  0.62  0.78  - 
Yale  Watkins et al. (2007)  N=122 
 
68-79 
(M:74) 
MADRS  2 wks 
3 ms 
Yes/ 
No‡ 
0.86 
0.95 
0.84 
0.89 
0.86 
0.93 
0.84 
0.91 
- 
ZSDS  Agrell and Dehlin (1989)  N=40 
 
 61-93 
(M: 80) 
MD & MIND 
Psychiatric interview 
4m-
2.5yrs 
≥45  0.76  0.96  0.93  0.84  - 
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a generalized anxiety disorder, agoraphobia with or without panic disorder, adjustment disorder with anxious mood, adjustment disorder with mixed anxiety 
and depressed mood and specific phobia
   
b generalized anxiety disorder, posttraumatic stress disorder, social phobia, agoraphobia, panic disorder with or without agoraphobia, anxiety not otherwise 
specified and obsessive compulsive disorder 
* standard cut-off score 
 highest sum of specificity and sensitivity 
‡ cutoff meeting recommended levels of sensitivity (≥.80) and specificity (≥.60) for stroke survivors (Bennett & Lincoln, 2006)  
- indicates data not reported 
ns indicates non-significant180      VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS 
 
 
 
 
Appendix C 
General Description of Self-Report Mood Screening Measures  
Note. A = anxiety; D = depression 
 
Measure  Type of 
distress  
No. of 
Items 
Response format  Period being 
measured 
Original population 
            BAI  A 
 
21  Multiple choice  Last week  General & psychiatric 
BDI  D 
 
21  Multiple choice  Last week  General & psychiatric 
BDI-II 
 
D  21  Multiple choice  Last 2 weeks  General & psychiatric 
BDI-FS 
 
D  7  Multiple choice  Last 2 weeks  Medical patients 
BASDEC 
 
D  19  Yes/No  Past  Elderly medical inpatients 
CES-D 
 
D  20  Multiple choice  Last week   General  
DISCs 
 
D  1  VAS  That day  Acquired Brain injury  
DT  A & D  1  VAS  Last week  Cancer 
GHQ-28 
 
A & D  28  Multiple choice  Last few weeks  General and psychiatric 
GHQ-30  A & D   30  Multiple choice  Last few weeks   
GDS 
 
D  30  Yes/No  Past week  Elderly 
GDS-15 
 
D  15  Yes/No  Past week  Elderly 
HADS  A & D  14  Multiple choice   Last week  Medical patients 
PHQ-9 
 
D  9  Multiple choice  Last 2 weeks  Primary care 
PHQ-2 
 
D  2  Multiple choice  Last 2 weeks  Primary care 
Smiley 
 
 
D  3  VAS  Last week  Stroke 
SIDI 
 
D  30  Yes/No  Current   Stroke inpatients  
SCL-90 
 
D  90  Multiple choice  Last week  Psychiatric and medical 
VASES 
 
A & D  10  VAS  Current  Aphasic population 
VAMS 
 
A & D  7  VAS  Current  Neurological population 
VAMS-S  A & D  1  VAS  Current  Neurological population 
WDI 
 
D  12  Multiple choice  Current  Psychiatric population 
YALE 
 
D  1  Yes/No  Current  Elderly patients 
ZDRS 
 
D  20  Multiple choice  Past few days  Psychiatric population       VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS   181 
 
 
 
Appendix D 
Local Stroke Unit Mood Assessment Pathway   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Within first 7 days/before discharge therapists /nursing 
staff to complete mood screening  
 
Can you use Yale Questions? 
 
Within first 7 days/before 
discharge MDT to complete 
mood screening using SADQ-
H10 (involve relatives if 
appropriate) 
 
Yes - The patient is able to communicate 
and understand simple questions?  
(Reliable YES/NO) 
 
No - The patient has severe 
communication difficulties?  
(Unreliable YES/NO) 
HADS  
If has visual impairment read 
out the question to patient. 
Re–assess at appropriate 
time intervals 
 
DISCs 
 If has visual impairment 
read out the question to 
patient. Re–assess at 
appropriate time intervals 
 
 
Does the person have mild/moderate 
communication difficulties? 
Repeat SADQH-
10 at 
appropriate 
time intervals 
 
YES  NO 
Use Yale Questions 
*If communication problems are present 
ensure use of communication aid.* 
 
Has the patient answered ‘yes’ to either/both 
Yale Questions? 
YES  NO 
Re-Assess mood using 
Yale Q at weekly 
intervals 182      VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS 
 
 
 
Appendix E 
Written Permission to Use the DT and PL 
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Appendix F 
Focus Group Information Sheet and Consent Form 
 
 
 
 
 
Focus Group Information Sheet  
 
Project title: Validation of the Distress Thermometer in Stroke 
 
Researcher: Rachael Gilson, Trainee Clinical Psychologist  
 
Ethics number: 561 
 
I would like to invite you to take part in a focus group to discuss how a mood assessment 
tool  called  the  Distress  Thermometer  can  be  adapted  for  use  with  people  who  have 
experienced a stroke. The following will give you a short overview of what will be involved.  
 
Please read the following information carefully before deciding to take part. If you are 
happy to participate you will be asked to sign a consent form at the end of this pack, which 
you can return in the stamped addressed envelope provided.  
 
Who is running the focus group? 
My name is Rachael Gilson. I am a Trainee Clinical Psychologist studying at the University of 
Southampton. As part of my doctorate in Clinical Psychology, I am working with the Clinical 
Psychology  team  at  Salisbury  District  Hospital.  My  supervisor  is  Kate  Jenkins,  Clinical 
Psychologist. 
 
What is the focus group about? 
The aim of this focus group is to produce an adapted version of the Distress Thermometer 
for people who have experienced a stroke. It is hoped that this will be implemented on the 
unit and form part of the mood assessment pathway.  
 
What is the Distress Thermometer? 
The  Distress  Thermometer  is  a  mood  assessment  tool  which  has  been  created  and 
validated for use with oncology patients. It consists of a 10-point visual scale in the form of 
a  thermometer,  and  a  ‘problem  list’.  The  person  completing  the  measure  is  asked  to 
indicate their current level of distress by using the scale. They are then asked to indicate 
which items, listed on a ‘problem list’, have been distressing for them over the past week.  
 
Why does the Distress Thermometer need to be adapted? 
All  patients  should  be  screened  within  6  weeks  of  diagnosis  to  identify  any  mood 
disturbances  (NICE,  2010).  However,  guidelines  do  not  specify  which  measures  to  use. 
Therefore,  local  service  providers  are  required  to  develop  their  own  guidelines  and 184      VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS 
 
 
 
protocols. The Distress Thermometer offers a holistic measure of global distress. It differs 
from other mood assessment tools which tend to pathologies mood disturbances. It also 
guides referral decisions when taking into account why the person is feeling distressed.  
 
 
What will be involved? 
A  focus  group  is  simply  a  group  ‘focused’  on  a  particular  topic.  You  will  be  asked  to 
comment on how the Distress Thermometer could be adapted for use with people who 
have experienced a stroke. There are no right or wrong answers. The group simply aims to 
capture your views. Discussions during the focus group will be audio-taped, transcribed 
(written down) and analysed to aid the development of an adapted version.  
 
Following the focus group, you will be given a copy of the transcript and adapted Distress 
Thermometer to comment on.  
 
How long will the group last for? 
The group is expected to last for a maximum of 2 hours. Refreshments will be provided. 
 
How many people will be involved? 
The focus group will involve a maximum of 8 people and 2 facilitators. Participants will be 
professionals working on Farley stroke unit and a service user representative.   
 
When and where will it happen? 
The focus group will take place at Salisbury District Hospital. If you are interested in taking 
part, you will be contacted to arrange a convenient date and time. This is likely to occur 
sometime in October 2011. 
 
Why am I being invited to take part? 
You are being asked to take part in this focus group as you either form part of the multi-
disciplinary team on Farley Unit or you have experienced a stroke and represent other 
service users. As a result, you are likely to know about the types of issues which result in 
someone feeling distressed after a stroke. 
 
Are there any benefits in taking part? 
An adapted version of the Distress Thermometer will be created and implemented on the 
unit. The effectiveness and validity of the Distress Thermometer will then be evaluated.  
 
Do I have to take part? 
No. It is up to you to decide whether or not to take part in this study.  
 
When do I need to decide by? 
If  you  decide  to  take  part,  please  complete  the  attached  consent  form  by  the  30
th 
September and return it in the stamped addressed envelope provided.  
 
What if I change my mind about taking part? 
You have the right to withdraw from the focus group at any time without giving a reason 
and without your decision impacting on future interactions with Southampton University or 
Salisbury District Hospital. 
 
Will my participation be confidential?       VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS   185 
 
 
 
Yes. Compliance with the 1998 Data Protection Act and the University of Southampton 
ethics policy will be maintained at all times.  
 
You will be given a pseudonym so that you are not identifiable in the typed transcription. 
The tapes will not be heard by anyone other than the researchers. All tapes will be stored 
securely in locked premises and electronic material will be password protected. Audiotapes 
will be destroyed confidentially after five years.   
 
 
The transcripts may be used in future publications, reports and research. However, in all 
cases, you will not be identifiable as all quotations will be anonoymised. 
 
Are there any risks involved? 
There are no foreseeable risks identified.  However, if you have any questions about your 
rights as a participant in the study or if you feel that you have been placed at risk or have a 
complaint, please contact:  
 
The Chair of the Ethics Committee 
Department of Psychology  
University of Southampton  
Southampton 
SO17 1BJ.  
Tel:  023 8059 5578 
 
Where can I get more information from? 
If you would like any further information or wish to discuss participating in the 
focus group, please contact me or Kate Jenkins on: 
 
Rachael Gilson, Trainee Clinical Psychologist, University of Southampton 
E-mail: rcg1g09@soton.ac.uk 
Tel: 0777 33 42190 
 
Kate Jenkins, Clinical Psychologist, Salisbury District Hospital 
E-mail: kate.jenkins@salisbury.nhs.ukTel: 01722 425105 
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Focus group consent form 
 
 
Project title: Validation of the Distress Thermometer in Stroke 
 
Facilitator: Rachael Gilson, Trainee Clinical Psychologist 
   
Ethics number: 561 
 
 
Please initial the boxes if you agree with the following statements:   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name (print name)………………………………………………………………………..……………… 
 
 
Signature ……………….…………………………………………………………………………………….. 
 
 
Date………………………………………………………………………………………………………………   
 
Contact telephone number….............................................................................. 
 
 
Email address………………………………………………………………………..………………………. 
 
 
I have read and understood the information sheet (18/09/11 Version 1), and I have 
had the opportunity to ask questions about the focus group 
 
I agree to take part in the focus group and I agree for my data to be used for the 
purpose of future reports, service evaluation and research 
 
I understand my participation is voluntary and I may withdraw at any time without my 
legal rights being affected 
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Appendix G 
 
Original 38-Item Problem List (National Comprehensive Cancer Network, 2011) 
 
 
 
Practical problems 
 
Family problems  Emotional problems   Physical problems  Spiritual/religious concerns 
            Child care  Dealing with children  Depression  Appearance  Getting around  Spiritual/religious concerns 
Housing  Dealing with partner  Fears  Bathing/dressing  Indigestion   
Insurance/financial  Ability to have children  Nervousness  Breathing  Memory/concentration   
Transportation  Family health issues  Sadness  Changes in urination  Mouth sores   
Work/school    Worry  Constipation  Nausea   
Treatment decisions    Loss of interest in usual activities  Diarrhea  Nose dry/congested   
      Eating  Pain   
      Fatigue  Sexual   
      Feeling swollen  Skin dry/itchy   
      Fevers  Sleep   
        Tingling in feet   188      VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS 
 
 
 
Appendix H 
Focus Group Structure  
 
 
Group stages  Content  Questions 
Introductions 
20 minutes 
Welcome participants 
Explain aim and structure of 
group (timing) 
Ground rules: confidentiality, 
no right or wrong answers 
Group introductions 
“name and role within stroke care” 
“What do you think of the DT?” 
Silent 
generation of 
ideas 
15 minutes 
Each participant is asked to 
write down/think about their 
answers to the following 
three questions:   
“How would you adapt the DT to meet 
the experiences of someone who has 
suffered a stroke? On the paper in 
front of you jot down your answers to 
the following three questions:” 
1)  Which items should be 
excluded from the list? 
2)  Which items should be kept? 
3)  What should be added to the 
list? 
Listing ideas on 
flipchart/round-
robin phase 
15 minutes 
Ask each person in turn to 
share one item which they 
have written down (under 
the 3 headings) 
 
Discussion of 
ideas on flip 
chart 
30 minutes 
Discussion around ideas to 
clarify, elaborate, defend or 
dispute items 
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Appendix I 
Focus Group Results 
 
 
 
 
 
 
 
 
 
 
 
Items added  Items removed  Items altered  Items kept 
        Speech – 
communication 
Breathing  Money/insurance  Child care 
Care arrangements  Feeling swollen  Driving/transportation  Treatment 
decisions 
Home environment  Fevers  Work  Ability to have 
children 
Leaving hospital  Indigestion  Children  Family health 
issues 
Hobbies  Mouth sores  Partner/carers  Depression 
Anger  Nose 
dry/congested 
Pets  Fears 
Communication  Skin dry/itchy  Continence  Nervousness 
Dizziness    Eating/drinking  Sadness 
Muscle weakness    Mobility  Worry 
Swallowing    Washing/dressing  Loss of interest in 
usual activities 
Vision    Concentration  Appearance 
Confusion    memory  Fatigue 
      Nausea 
      Pain 
      Sexual 
      Sleep  
      Tingling in 
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Appendix J 
Adapted Problem List and Corresponding ICF Codes Based Within the ICF Core Set for 
Stroke (Geyh, et al., 2004) 
PL items  ICF Code  ICF category title 
      Care arrangements  e340 
e355 
e360 
e450 
e455 
e580 
Personal care providers and personal assistants 
Health professionals 
Health-related professionals 
Individual attitudes of health professionals 
Individual attitudes of health-related professionals 
Health services, systems and policies 
Child care  (d660)  Assisting others 
Driving/transportation  d475 
d470 
e540 
Driving 
Using transport 
Transportation services, systems and policies 
Home environment  e525  Housing services, systems and policies 
Leaving hospital  -  - 
Money/insurance  d870  Economic self-sufficiency 
Treatment decisions  -  - 
Work  d845 
d850 
d855 
Acquiring, keeping and terminating a job 
Remunerative employment 
Non-remunerative employment 
Hobbies  d920  Recreation and leisure  
Children  e310  Immediate family 
Partner/carers  e310 
e340 
Immediate family 
Personal care providers and personal assistants 
Pets  (e350)  (Domesticated animals) 
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Table J1 continued     
PL items  ICF Code  ICF category title 
      Ability to have children  (b660)  (Procreation functions) 
Family health issues  e310  Immediate family 
Anger  b152  Emotional functions 
Depression  b152  Emotional functions 
Fears  b152  Emotional functions 
Nervousness  b152  Emotional functions 
Sadness  b152  Emotional functions 
Worry  b152  Emotional functions 
Loss of interest in usual activities  b152  Emotional functions 
Appearance  -  - 
Communication  b167 
d310 
d315 
d325 
d330 
d335 
d345 
d360 
Mental functions of language 
Communicating with–receiving–spoken messages 
Communicating with–receiving–nonverbal 
messages 
Communicating with–receiving–written messages 
Speaking 
Producing nonverbal messages 
Conversation 
Using communication devices and techniques 
  d360  Conversation 
Using communication  devices and techniques 
Toileting  d530 
b525 
b620 
Toileting  
Defecation functions 
Urination functions 
Dizziness  (b240)  Sensations associated with hearing and vestibular 
function 
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Table J1 continued     
PL items  ICF Code  ICF category title 
      Eating/drinking  d550 
(d560)  
Eating 
Drinking 
Fatigue  b134  Sleep functions 
Movement  d450 
d455 
d460 
d465 
Walking 
Moving around 
Moving around in different locations 
Moving around using equipment 
Muscle weakness  b730  Muscle power functions 
Nausea  (b535)  (Sensations associated with the digestive system) 
Pain  b280  Sensations of pain 
Sexual  b640 
d770 
Sexual functions 
Intimate relationships 
Sleep  b134  Sleep functions 
Swallowing  b510  Ingestion functions 
Tingling in hands and feet  b265  Touch functions 
Vision  b210 
b215 
Seeing functions 
Functions of structures adjoining the eye 
Washing and dressing  d510 
d540 
Washing oneself 
Dressing 
Confusion  b114  Orientation functions 
Concentration  b140  Attention functions 
Memory   b144  Memory functions 
Spiritual/religious concerns  (d930)  (Religion and spirituality) 
Note. ICF = International Classification of Functioning, Disability and Health 
The brief ICF Core Set for Stroke are shown in boldface. Items not detailed within the ICF 
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Appendix K 
Stroke Unit Information Sheet and Consent Form 
 
  
 
 
 
Participant Information Sheet 
 
 
Study title: Validation of the Distress Thermometer in Stroke 
 
Researcher: Rachael Gilson, Trainee Clinical Psychologist  
 
Ethics number: 561 
 
I would like to invite you to take part in a study which is looking at the usefulness of a 
mood assessment tool called the Distress Thermometer.  
 
The following information will give you a short overview of what will be involved. 
 
Please read the following information carefully before deciding to take part in this study. If 
you are happy to participate you will be asked to sign a consent form. 
 
Who is running the study? 
My name is Rachael Gilson. I am a Trainee Clinical Psychologist studying at the University of 
Southampton. As part of my doctorate in Clinical Psychology, I am working with the Clinical 
Psychology  team  at  Salisbury  District  Hospital.  My  supervisor  is  Kate  Jenkins,  Clinical 
Psychologist.  
 
What is the study about? 
As part of my third year dissertation I am looking into the effectiveness of a questionnaire 
called the Distress Thermometer. The Distress Thermometer measures the level and cause 
of someone’s distress. It was created for use with people who have experienced cancer, 
however,  this  study  aims  to  investigate  whether  it  is  useful  for  people  who  have 
experienced a stroke.   
 
Why am I being invited to take part? 
The National Clinical Guideline for Stroke (2008) highlights the importance of identifying 
someone’s emotional needs while in hospital and at regular intervals once they have left 
hospital. While this is currently happening on Farley Unit, it is hoped that the addition of 
the Distress Thermometer will enhance this process. 
 
What will be involved? 
You will be asked to complete three questionnaires, including the Distress Thermometer, 
which assess how you have been feeling over the last few days.  You will also be asked to 194      VALIDATION OF THE DISTRESS THERMOMETER AMONG STROKE SURVIVORS 
 
 
 
complete  a  number  of  tasks  which  measure  your  thinking  skills,  such  as  memory  and 
concentration. 
 
How long will this take? 
It is expected that this will take between 30-60 minutes. 
 
What will happen once I have completed the questionnaires? 
After completing the questionnaires, your results will be fed back to you. If you would like 
to receive any further support with regard to how you are feeling, you will be given the 
opportunity to discuss this after completing the questionnaires and additional support will 
be arranged where appropriate.  
 
Will my participation be confidential? 
Compliance with the 1998 Data Protection Act and the University of Southampton ethics 
policy will be maintained at all times.  
 
As part of your routine care on Farely Unit, the completed questionnaires will be kept in 
your medical file along with details of any further recommendations and referrals. This 
information will only be accessible to professionals who are involved in your care. If you do 
not want this to happen please indicate this on the consent form. However, if during the 
completion of the questionnaires you raise concerns about your safety or the safety of 
others, this will need to be discussed with other professionals. 
   
To  evaluate  the  effectiveness  of  the  Distress  Thermometer,  your  results  will  be 
anonymised, so that nobody can identify you, data coded and transferred to a password 
protected computer for analysis. This data will then be used to write and publish academic 
articles.  
 
If after the study you would like to receive a summary of the findings or a copy of any 
written articles, please contact Rachael Gilson, at the below details.    
 
Are there any benefits in taking part? 
Your participation has the potential to shape future practice within stroke services with 
regard to the assessment and treatment of someone’s emotional needs after stroke.  
  
Do I have to take part? 
No. It is up to you to decide whether or not to take part in this study.  
 
What if I change my mind about taking part? 
You have the right to withdraw from the study at any time without giving a reason and 
without your decision impacting on future interactions with Southampton University or 
Salisbury District Hospital. 
 
Are there any risks involved? 
The questionnaires involve talking about how you have been feeling following your stroke. 
Understandably, this may be upsetting for you at times.  
 
 
What happens if something goes wrong? 
If you have any questions about your rights as a participant in the study or if you feel that 
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The Chair of the Ethics Committee 
Department of Psychology  
University of Southampton  
Southampton 
SO17 1BJ.  
Tel:  023 8059 5578 
Where can I get more information from? 
If you would like any further information or wish to discuss participating in this 
study, please contact me or Kate Jenkins on: 
 
Rachael Gilson, Trainee Clinical Psychologist, University of Southampton 
E-mail: rcg1g09@soton.ac.uk 
Tel: 0777 33 42190 
 
Kate Jenkins, Clinical Psychologist, Salisbury District Hospital 
E-mail: kate.jenkins@salisbury.nhs.ukTel: 01722 425105 
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Consent form 
 
 
Focus group topic: Validation of the Distress Thermometer in stroke 
 
Facilitator: Rachael Gilson, Trainee Clinical Psychologist 
   
Ethics number: 561 
 
 
Please initial the boxes if you agree with the following statements:   
 
 
I have read and understood the information sheet (date/version 2),  
and I have had the opportunity to ask questions about the study 
 
 
 
I agree to take part in this study and I agree for my data to be used                  
for the purpose of future reports and research 
 
 
 
I agree for the completed questionnaires to be kept within my medical 
file 
 
 
I understand my participation is voluntary and I may withdraw                 
at any time without my legal rights being affected  
 
 
 
Name (print name)…………………………………………………………………… 
 
 
Signature ……………….…………………………………………………………….. 
 
 
Date……………………………………………………………………………………   
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Appendix L 
Charity Information Sheet and Consent Form 
 
 
 
 
 
 
Participant Information Sheet 
 
 
Study title: Validation of the Distress Thermometer in Stroke 
 
Researcher: Rachael Gilson, Trainee Clinical Psychologist  
 
Ethics number: 561 
 
I would like to invite you to take part in a study which is looking at the effectiveness of a 
mood assessment tool called the Distress Thermometer. The following information will give 
you a short overview of what will be involved. 
 
Please read the following information carefully before deciding to take part in this study. If 
you are happy to participate you will be asked to sign a consent form which you can return 
in the stamped addressed envelope provided.  
 
Who is running the study? 
My name is Rachael Gilson. I am a Trainee Clinical Psychologist studying at the University of 
Southampton. As part of my doctorate in Clinical Psychology, I am working with the Clinical 
Psychology  team  at  Salisbury  District  Hospital.  My  supervisor  is  Kate  Jenkins,  Clinical 
Psychologist.  
 
What is the study about? 
As  part  of  my  third  year  dissertation  I  am  investigating  the  effectiveness  of  a  mood 
assessment measure called the Distress Thermometer, which measures the level and cause 
of someone’s distress. It is used with people who have experienced cancer, however, this 
study aims to investigate whether it is useful for people who have experienced a stroke.   
 
Why am I being invited to take part? 
You  are  being  asked  to  take  part in  this  study  as  you  have  experienced  a  stroke.  The 
National  clinical  guideline  for  Stroke  (2008)  highlight  the  importance  of  identifying 
someone’s “emotional” needs while in hospital and at regular intervals once they have left 
hospital. However, these guidelines do not specify how to do this.  
 
What will be involved? 
You will be asked to complete three questionnaires, including the Distress Thermometer, 
which assess how you have been feeling over the last few days.  You will also be asked to 
complete  a  number  of  tasks  which  measure  your  thinking  skills,  such  as  memory  and 
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How long will this take? 
It is expected that this will take between 30-60 minutes. 
 
 
Will my participation be confidential? 
Yes. Compliance with the 1998 Data Protection Act and the University of Southampton 
ethics policy will be maintained at all times.  
 
The questionnaires will remain anonymous so nobody can identify you. Your scores will be 
data coded and transferred to a password protected computer for analysis.  
 
Are there any benefits in taking part? 
Your participation has the potential to shape future practice within stroke services with 
regard to the assessment and treatment of someone’s emotional needs after stroke.  
  
Do I have to take part? 
No. It is up to you to decide whether or not to take part in this study.  
 
What do I need to do if I decide to take part? 
If you decide to take part, please complete the attached consent form and return it in the 
stamped addressed envelope provided.  
 
I  will  then  contact  you  to  arrange  a  convenient  time  and  place  to  complete  the 
questionnaires.   Any  travel  expenses will  be  paid  for  and  you  will  be  given a  £5  M&S 
voucher for your time.  
 
What if I change my mind about taking part? 
You have the right to withdraw from the study at any time without giving a reason and 
without your decision impacting on future interactions with Southampton University or 
Salisbury District Hospital. 
 
Are there any risks involved? 
Several of the questionnaires involve talking about how you have been feeling following 
your stroke. Understandably, this may be upsetting for you at times. The results of the 
questionnaires will be fed back to you once completed. If at the end of the session you 
would like to receive additional support, this can be discussed and local services/resources 
will be made available to you where appropriate.  
 
What happens if something goes wrong? 
If you have any questions about your rights as a participant in the study or if you feel that 
you have been placed at risk or have a complaint, please contact:  
 
The Chair of the Ethics Committee 
Department of Psychology  
University of Southampton  
Southampton 
SO17 1BJ.  
Tel:  023 8059 5578 
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Where can I get more information from? 
If you would like any further information or wish to discuss participating in this study, 
please contact me or Kate Jenkins on: 
 
Rachael Gilson, Trainee Clinical Psychologist, University of Southampton 
E-mail: rcg1g09@soton.ac.uk 
Tel: 0777 33 42190 
 
Kate Jenkins, Clinical Psychologist, Salisbury District Hospital 
E-mail: kate.jenkins@salisbury.nhs.uk 
Tel: 01722 425105 
 
 
If at the end of the study you would like to receive a summary of the findings please 
contact Rachael Gilson at the above details.  
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Consent form 
 
 
Study title: Validation of the Distress Thermometer in Stroke 
 
Researcher: Rachael Gilson, Trainee Clinical Psychologist 
 
Ethics number: 561 
   
 
Please initial the boxes if you agree with the following statements:   
 
 
I have read and understood the information sheet (09/01/12/version 3),               
and I have had the opportunity to ask questions about the study 
 
 
 
I agree to take part in this study and I agree for my data to be used                  
for the purpose of future reports and research 
 
 
I understand my participation is voluntary and I may withdraw                          
at any time without my legal rights being affected  
 
 
 
Name (print name)…………………………………………………………………… 
 
 
Signature ……………….…………………………………………………………….. 
 
 
Date……………………………………………………………………………………   
 
Contact telephone number………………………………………………………… 
 
or  
 
Email address…………………………………………………………………………. 
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Appendix O 
Table O1  
Screening Properties of the Distress Thermometer (DT) Relative to the HADS  
DT   HADS-D ≥8  HADS-D ≥4  HADS-A ≥8  HADS-A ≥4  HADS-T ≥11 
Cut 
off  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV 
≥1  1.00  0.00  0.32  1.00  0.90  0.10  0.68  0.33  0.90  0.10  0.32  0.67  0.96  0.25  0.79  0.67  0.94  0.15  0.61  0.67 
≥2  1.00  0.24  0.39  1.00  0.86  0.20  0.69  0.40  0.90  0.19  0.35  0.80  0.96  0.50  0.85  0.80  0.94  0.31  0.65  0.80 
≥3  0.90  0.33  0.39  0.88  0.81  0.40  0.74  0.50  0.80  0.29  0.35  0.75  0.91  0.75  0.91  0.75  0.89  0.46  0.70  0.75 
≥4  0.90  0.48  0.45  0.91  0.71  0.50  0.75  0.46  0.80  0.43  0.40  0.82  0.83  0.88  0.95  0.64  0.83  0.62  0.75  0.73 
≥5  0.80  0.62  0.50  0.87  0.67  0.80  0.88  0.53  0.70  0.57  0.44  0.80  0.65  0.88  0.94  0.47  0.72  0.77  0.81  0.67 
≥6  0.50  0.76  0.50  0.76  0.38  0.80  0.80  0.38  0.50  0.76  0.50  0.76  0.39  0.88  0.90  0.33  0.39  0.77  0.70  0.48 
≥7  0.30  0.90  0.60  0.73  0.19  0.90  0.80  0.35  0.40  0.95  0.80  0.77  0.22  1.00  1.00  0.31  0.22  0.92  0.80  0.47 
≥8  0.10  0.95  0.50  0.69  0.05  0.90  0.50  0.31  0.10  0.95  0.50  0.69  0.09  1.00  1.00  0.28  0.06  0.92  0.50  0.41 
≥9  0.10  1.00  1.00  0.70  0.05  1.00  1.00  0.33  0.10  1.00  1.00  0.70  0.04  1.00  1.00  0.27  0.06  1.00  1.00  0.43 
=10  0.00  1.00  1.00  0.68  0.00  1.00  1.00  0.32  0.00  1.00  1.00  0.68  0.04  1.00  1.00  0.27  0.06  1.00  1.00  0.43 
Prevalence (%) 
 
 
 
32.3 
 
 
 
  67.7    32.3    74.2      58.1 
Area under curve 
 
0.74**    0.67    0.68    0.86**      0.74* 
Note. Se = sensitivity; Sp = specificity; PPV = positive predictive value; NPV = negative predictive value 
* p<0.05  **p<0.001    
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Table O2  
Screening Properties of the Brief Assessment Schedule Depression Cards (BASDEC) Relative to the HADS  
Note. Se = sensitivity; Sp = specificity; PPV = positive predictive value; NPV = negative predictive value 
 
 
BASDEC  HADS-D ≥8  HADS-D ≥4  HADS-A ≥8  HADS-A ≥4  HADS-T ≥11 
Cut off  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV 
≥2  1.00  0.24  0.39  1.00  0.81  0.10  0.65  0.20  1.00  0.24  0.39  1.00  0.87  0.25  0.77  0.40  0.89  0.23  0.62  0.60 
≥2.5  0.80  0.33  0.36  0.78  0.67  0.20  0.64  0.22  0.80  0.33  0.36  0.78  0.74  0.38  0.77  0.33  0.78  0.38  0.64  0.56 
≥3  0.80  0.38  0.38  0.80  0.67  0.30  0.67  0.30  0.80  0.38  0.38  0.80  0.74  0.50  0.81  0.40  0.78  0.46  0.67  0.60 
≥3.5  0.70  0.62  0.47  0.81  0.48  0.50  0.67  0.31  0.70  0.62  0.47  0.81  0.52  0.63  0.80  0.31  0.61  0.69  0.73  0.56 
≥4  0.70  0.67  0.50  0.82  0.48  0.60  0.71  0.35  0.70  0.67  0.50  0.82  0.52  0.75  0.86  0.35  0.61  0.77  0.79  0.59 
≥4.5  0.60  0.71  0.50  0.79  0.43  0.70  0.75  0.37  0.60  0.71  0.50  0.79  0.43  0.75  0.83  0.32  0.50  0.77  0.75  0.53 
≥5  0.60  0.71  0.50  0.79  0.43  0.70  0.75  0.37  0.60  0.71  0.50  0.79  0.43  0.75  0.83  0.32  0.50  0.77  0.75  0.53 
≥5.5  0.40  0.76  0.44  0.73  0.33  0.80  0.78  0.36  0.60  0.86  0.67  0.82  0.39  1.00  1.00  0.36  0.39  0.85  0.78  0.50 
≥6  0.40  0.76  0.44  0.73  0.33  0.80  0.78  0.36  0.60  0.86  0.67  0.82  0.39  1.00  1.00  0.36  0.39  0.85  0.78  0.50 
≥6.5  0.40  0.86  0.57  0.75  0.29  0.90  0.86  0.38  0.50  0.90  0.71  0.79  0.30  1.00  1.00  0.33  0.33  0.92  0.86  0.50 
≥7  0.30  0.86  0.50  0.72  0.23  0.90  0.83  0.36  0.40  0.90  0.67  0.76  0.26  1.00  1.00  0.32  0.28  0.92  0.83  0.48 
Prevalence (%) 
 
 
 
32.3    0.68    0.32    0.74    0.58 
Area under curve 
 
0.68    0.51    0.73    0.68    0.67  
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Table O3 
Screening Properties of the Yale Question (YQ2) Relative to the HADS  
Note. Se = sensitivity; Sp = specificity; PPV = positive predictive value; NPV = negative predictive value; YQ2 = Yale question; HADS-D = Hospital 
Anxiety and Depression Scale – depression subscale; HADS-A = Hospital Anxiety and Depression Scale – anxiety subscale; HADS-T = Hospital Anxiety 
and Depression Scale – total score 
 
 
 
 
 
YQ2  HADS-D ≥8  HADS-D ≥4  HADS-A ≥8  HADS-A ≥4  HADS-T ≥11 
Cut off  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV  Se  Sp  PPV  NPV 
=1  0.67  0.67  0.46  0.82  0.45  0.60  0.69  0.35  0.44  0.57  0.31  0.71  0.64  0.63  0.82  0.39  0.47  0.62  0.62  0.47 
Prevalence (%) 
 
 
 
30.0    66.7    30.0    73.3    56.7 
Area under curve 
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Appendix P 
Number and Percent of Items Selected on the Problem List  
    N (%) 
Domain  Item 
Total  
(N = 31) 
Inpatient 
(n = 21) 
Charity 
(n = 10) 
          Practical problems  Care arrangements  6 (19.4)  4 (19.0)  2 (20.0) 
Child care  -  -  - 
Driving  9 (29.0)  7 (33.3)  2 (20.0) 
Home environment  5 (16.1)  5 (23.8)  - 
Leaving hospital  4 (12.9)  4 (19.0)  - 
Money  5 (16.1)  3 (14.3)  2 (20.0) 
Treatment decisions  5 (16.1)  4 (19.0)  1 (10.0) 
Work  2 (6.5)  1 (4.8)  1 (10.0) 
Hobbies  3 (9.7)  3 (14.3)  - 
          
Family concerns  Children  7 (22.6)  4 (19.0)  3 (30.0) 
  Partner  3 (9.7)  3 (14.3)  - 
  Pets  3 (9.7)  3 (14.3)  - 
  Ability to have children  -  -  - 
  Family health issues  7 (22.6)  4 (19.0)  3 (30.0) 
          
Emotional problems  Anger  7 (22.6)  5 (23.8)  2 (20.0) 
  Depression  9 (29.0)  7 (33.3)  2 (20.0) 
  Fears  9 (29.9)  9 (42.9)  - 
  Nervousness  7 (22.6)  6 (28.6)  1 (10.0) 
  Sadness  12 (38.7)  6 (28.6)  6 (60.0) 
  Worry  13 (41.9)  6 (28.6)  7 (70.0) 
  Loss of interest  7 (22.6)  6 (28.6)  1 (10.0) 
          
Physical problems  Appearance   8 (25.8)  6 (28.6)  2 (20.0) 
  Communication  6 (19.4)  4 (19.0)  2 (20.0) 
  Toileting  5 (16.1)  4 (19.0)  1 (10.0) 
  Dizziness  6 (19.4)  6 (28.6) 
 
- 
  Eating  3 (9.7)  3 (14.3)  - 
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Table P1 continued         
    N (%) 
Domain  Item 
Total  
(N = 31) 
Inpatient 
(n = 21) 
Charity 
(n = 10) 
            Fatigue  16 (51.6)  11 (52.4)   5 (50.0) 
  Movement  19 (61.3)  13 (61.9)  6 (60.0) 
  Muscle weakness   19 (61.3)  13 (61.9)  6 (60.0) 
  Nausea  2 (6.5)  2 (9.5)  - 
  Pain  5 (16.1)  4 (19.0)  1 (10.0) 
  Sexual  2 (6.5)  1 (4.8)  1 (10.0) 
  Sleep  11 (35.5)  9 (42.9)  2 (20.0) 
  Swallowing  6 (19.4)  5 (23.8)  1 (10.0) 
  Tingling   9 (29.0)  7 (33.3)  2 (20.0) 
  Vision  9 (29.0)  6 (28.6)  3 (30.0) 
  Washing/dressing  4 (12.9)  4 (19.0)  - 
          
Thinking problems  Confusion  3 (9.7)  3 (14.3)  - 
  Concentration  5 (16.1)  4 (19.0)  1 (10.0) 
  Memory  12 (38.7)  6 (28.6)  6 (60.0) 
          
Spiritual/religious concerns  Spiritual concerns  1 (3.2)  1 (4.8)  - 
Note. N = number 
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Appendix Q 
Post-Hoc Power Analysis 
 
Field (2009, p. 58) states that “the power of a test is the probability that a given test 
will find an effect assuming that one exists in the population”. GPower 3.1.2 was 
used to calculate the post-hoc power for an effect size of rs = .22. When the standard 
α-level was .05 and the total sample size was N=31, power was 0.23, which was well 
below a level of .80 (Cohen, 1992). Consequently, future research is needed to 
replicate this study using a larger sample to clarify whether an association between 
the BASDEC and HADS-D exists. According to Cohen (1992), a sample size greater 
than 85 cases would be needed when the correlation r is less than or equal to .30, as 
detailed below 
 
Effect size  Correlation r  % shared variance  Minimum number of people 
required  Large  .50  25%  28 
Medium  .30  9%  85 
Small  .10  1%  783 
 